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Summary 
 
Fluorescence time-lapse imaging has become a powerful tool to investigate complex 
dynamic processes such as cell division or intracellular trafficking. Automated 
microscopes generate time-resolved imaging data at high throughput, yet tools for 
quantification of large-scale movie data are largely missing. Here, we present 
CellCognition, a computational framework to annotate complex cellular dynamics. 
We developed a machine learning method that combines state-of-the-art classification 
with hidden Markov modeling for annotation of the progression through 
morphologically distinct biological states. The incorporation of time information into 
the annotation scheme was essential to suppress classification noise at state 
transitions, and confusion between different functional states with similar 
morphology. We demonstrate generic applicability in a set of different assays and 
perturbation conditions, including a candidate-based RNAi screen for mitotic exit 
regulators in human cells. CellCognition is published as open source software, 
enabling live imaging-based screening with assays that directly score cellular 
dynamics. 
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Introduction 
The availability of RNAi technology for high-throughput gene inactivation 
experiments, fluorescent protein labeling, and automated microscopy has opened a 
new era of screening possibilities in higher eukaryotes1. Indeed, imaging-based RNAi 
and chemical compound screening has become one of the most important discovery 
tools for the identification of new gene function, for example in the regulation of 
DNA damage and repair2, endocytosis3, mitosis4-6. 
Imaging-based screens typically assay altered incidence of cells with specific features 
within a population of fixed, fluorescently labeled cells. The development of 
computational methods for the automated annotation of high-throughput imaging data 
was key to establish microscopy-based screening as a routine technology in a wide 
research community. Especially machine learning for supervised classification of 
cellular morphologies is one of the most powerful annotation strategies7-12.   
Many biological processes depend on stochastic events and occur in an 
unsynchronized and transient manner, which limits the applicability of single time 
point assays. Particularly, complex dynamic processes such as cell division or 
intracellular trafficking demand for time-resolved live cell imaging13. Automated 
microscopes now enable live imaging with high throughput and spatio-temporal 
resolution1, 7, 14. Computational analysis of such data is challenging and existing 
machine learning and classification approaches do not provide sufficient accuracy to 
correctly annotate cellular trajectories with multiple time points. Published live 
imaging-based RNAi screens scored phenotypes either exclusively at the cell 
population level6, 7, or relied on visual evaluation of single cell dynamics4. However, 
cell population analysis cannot detect stochastic and transient phenotypes, and visual 
interpretation of morphological dynamics is very time consuming and often 
unreliable.  
To improve the classification accuracy of machine learning methods, the temporal 
context can be taken into account. For example, if the biological process underlying 
an assay is well known, a biological model can be explicitly defined in an error 
correction scheme that suppresses illegitimate stage transitions. This has been applied 
to the pattern of mitotic chromatin morphology changes11, 12. However, temporal error 
correction based on biological a priori models limits the detection of unexpected 
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phenotypic variations, and the adaptation to different biological questions requires re-
implementation of the underlying models by the user for each new assay.  
Here, we present CellCognition, an integrated computational strategy that combines 
machine learning methods for supervised classification and hidden Markov modeling 
to measure morphological dynamics in live cell microscopic movies. Our error 
correction method does not require a priori definition of the temporal progression, 
which enables its application to a wide range of assays and phenotypic variations. We 
demonstrate efficiency and sensitivity of the methodology in various assays and 
perturbation conditions.  
  5 
Results 
 
High-throughput imaging of cellular dynamics 
To visualize morphological dynamics of various cellular structures, we generated a 
collection of human HeLa reporter cell lines stably expressing different combinations 
of fluorescent markers. All cell lines expressed a red chromatin marker (core histone 
2B (H2B) fused to mCherry). In this background, we co-expressed markers for 
microtubules (mEGFP-α-tubulin), the Golgi apparatus (Galactosyl transferase (GalT) 
fused to EGFP), or DNA replication factories (proliferating cell nuclear antigen 
(PCNA) fused to mEGFP). This diverse set of secondary markers (Fig. 1a) provides a 
well-suited test case for the implementation of a generic annotation method. With 
these cells, we performed multi-location time-lapse imaging on an automated wide-
field epifluorescence microscope14. We typically recorded 96 movies in parallel, with 
a temporal resolution less than 5 min over a total duration of 24 h, generating datasets 
of about 100,000 images, or 200 Gigabyte, per day and microscope. The analysis of 
such a single experiment requires annotation of up to 25 million cellular 
morphologies derived from about 260,000 objects per movie with a 10x microscope 
objective. 
 
Machine learning and classification of morphologies 
Timing measurements in live cell imaging data are often based on the progression 
through distinct morphologies that relate to specific biological states. An excellent 
example for this is mitosis, for which the chromatin morphology can be used to 
annotate the canonical mitotic stages (Fig. 1b; Supplementary Movie 1). We decided 
to use this classic assay as a test case to measure timing events at the single cell level. 
We first implemented a canonical strategy for automated annotation of morphological 
classes7-9, 15, based on object detection, multivariate feature extraction, and supervised 
machine learning (Fig. 1c). We used local adaptive thresholding7, followed by a 
watershed split-and-merge segmentation error correction16 to detect individual cells at 
an accuracy of 95.7% (n = 1876 objects; 2.6% over-segmented (falsely cut objects); 
1.7% under-segmented (falsely merged objects)). A set of 186 quantitative features17, 
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18 (Supplementary Table 1, Supplementary Fig. 1) describing texture and shape was 
then calculated for each object. Next, a support vector machine classifier19 was 
trained for the discrimination of 8 different object morphologies (Fig. 1b; interphase, 
six different mitotic stages, and apoptosis). These classes were defined by manual 
annotation of 28 to 195 example objects. The match between human and computer 
annotation was 94.6% (mean of all classes; five-fold cross-validation), ranging 
between 75.0% for the early anaphase class, and 99.0% for interphase class (Fig. 1d). 
This performance is similar to a number of previously reported supervised machine 
learning applications 7, 9, 11, 20. Next, individual cells were tracked over time by a 
nearest-neighbor algorithm that supports trajectory splitting (e.g., cell division) and 
merging (e.g., cell-to-cell fusion). The automated tracking matched 99.8% of the 
human annotated object-over-frame connections (n = 1942), again comparable to the 
performance of previous studies on cell tracking11, 21.  
The overall accuracy of the individual computational steps appears high. However, 
considering >500 frames per cell trajectory for our time-resolved datasets, almost no 
error-free trajectories were obtained by this approach (Fig. 1e, Supplementary Movie 
2). 
 
Detecting scarce events in long-term movies 
Mitotic events are scarce in comparison to the much longer duration of interphase 
(Fig. 1e). To improve the sensitivity for mitotic stage annotation, we automatically 
selected mitotic events based on a morphology class sequence motif of prophase-
prometaphase. This yielded a sub-graph highly enriched for mitotic events (Fig. 2a; 
Supplementary Movie 3; 81.5% of all mitotic events were automatically extracted; n 
= 294 mitotic events in three movies). This set of trajectories contained 2.1% 
misclassifications per object (a posteriori compared with human annotation).   
Untrained biological users may annotate the classifier training set less reliably. To test 
the sensitivity of the support vector machine towards annotation errors, we 
randomized the labels on an increasing fraction of training objects, and measured the 
overall classification accuracy (Supplementary Fig. 2). Surprisingly, randomization of 
the labels on 50% of the training objects reduced the overall annotation accuracy only 
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slightly below 90%. This demonstrates that classification by support vector machine 
is relatively insensitive to annotation errors.  
  
Hidden Markov model for time-lapse imaging 
Single object-based machine learning and classification does not take the temporal 
context into account. However, objects with ambiguous morphologies occur within a 
typical context of preceding and following morphologies, which could help to derive 
correct annotation. This could be particularly relevant for gradual morphology 
changes at stage transitions, where single object-based classification is relatively 
inaccurate (e.g., interphase - prophase - interphase - interphase - prophase - 
prometaphase, see Fig. 2b or Supplementary Movie 3)  
We reasoned that taking the history of a cell into account might provide a means to 
correct for such noise at stage transitions, as well as confusion between closely related 
morphology classes. We assumed that the true state of a cell at a given time point (the 
mitotic stage in this assay) is not known, but that it correlates with an observed state 
(the morphology class prediction probabilities). We further assumed that the 
progression to the next state entirely depends on a given present state. This fulfils the 
criteria for a hidden Markov model, which can be used for error correction in time-
resolved data22.  
We built a model with five components: 1) hidden states, representing the true 
morphology classes (for example, mitotic stages), 2) observed states (the class 
prediction probability vectors of the support vector machine), 3) probabilities of 
hidden state transitions, 4) observation probabilities, and 5) initial probabilities of 
hidden states. All elements of this model were computationally derived from the data 
without further user interaction. The hidden states were defined by the initial class 
annotation, as described above (Fig. 1b). The observed states were derived from the 
support vector machine as a vector of class prediction probabilities for each time 
point. The hidden state probabilities were initialized at the first time point by the 
support vector machine predictions. Transition probabilities between hidden states 
were calculated based on the support vector machine prediction probabilities of all 
cellular trajectories per experimental condition (Fig. 2c, d), and the observation 
probabilities between hidden and observed states were estimated based on the 
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confusion matrix of the support vector machine. We derived the overall maximum 
likelihood path for the progression through mitosis by the Viterbi algorithm23 (thick 
black line in Fig. 2e). This increased the overall per-object accuracy to 99.0%. 
Iterative learning of transition probabilities by the expectation-maximization 
algorithm24, 25 did not improve prediction accuracy (98.1% after five iterations). We 
suspected that the confusion matrix overestimates observation probabilities, as classes 
that are difficult to discriminate (prophase and early anaphase) were over-represented 
in the annotation data. We therefore tested the performance of temporal error 
correction with lower error rates in the observation probabilities (0.1% for all 
transitions). Indeed, this eliminated noise at state transitions and corrected single 
frames of misclassified objects even more efficiently, yielding overall accuracy of 
99.4% per object, and 91% completely error-free trajectories (n = 100 trajectories; 
4,000 objects; Fig. 2f, Supplementary Fig. 3; Supplementary Movie 4).  
We next tested if incorporation of a priori biological knowledge on state transitions 
further increases the annotation accuracy. Specifically, we constrained the state 
transition graph to the forward direction of three consecutive classes, and defined 
apoptosis as a terminal state (Supplementary Fig. 4a, b). The probability matrix for 
constrained state transitions improved the error correction performance of the hidden 
Markov model to 99.7% per object, yielding 94% completely error-free trajectory 
annotations (n = 100 trajectories; 4,000 objects; Supplementary Fig. 4c).  
Temporal error correction by the hidden Markov model is expected to depend on 
good estimates of the predicted morphology classes. We therefore investigated the 
robustness of temporal error correction towards simulated classification noise. We 
randomized the class prediction probability vectors of an increasing fraction of 
objects, then learnt the hidden Markov model on the noisy trajectories, and applied it 
to correct classification errors (Supplementary Fig. 5). Comparison with manually 
annotated data demonstrated that the hidden Markov-based error correction improved 
the overall accuracy at all noise levels.  
We also tested if the temporal error correction was sensitive to changes in the time-
lapse interval by generating trajectories sampled to every 2nd up to every 6th time 
point (Supplementary Fig. 6). Comparison with the manually annotated labels showed 
that the hidden Markov model increased the overall annotation accuracy at all 
sampling intervals. 
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In conclusion, hidden Markov modeling provides a robust and efficient means to 
eliminate misclassifications and noise at morphology state transitions. The 
combination of mitotic event selection and hidden Markov error correction reduced 
the per-object error rate about 10-fold below single time point-based classification.  
 
Generic strategy for annotation of cellular dynamics 
We next used our tools for other assays and fluorescent markers. We were particularly 
interested in simultaneous analysis of multiple markers in the same cell, for example, 
to address temporal coordination of mitotic processes. We defined cytoplasmic areas 
based on their relative position to the chromatin marker, using non-overlapping region 
growing of the contours derived from the chromatin channel (Supplementary Fig. 7a, 
b). While this may be less precise than segmenting in the secondary channel, it proved 
to be robust over many different assays and was insensitive to temporal dynamics (see 
Fig. 3, 4, and below). Tracking results of the primary channel were applied to the 
secondary channel, and all subsequent analysis of temporal dynamics was performed 
independently for primary and secondary channels, as outlined above (see 
Supplementary Fig. 7c for workflow).  
We first applied our methods to movies from cells expressing mEGFP-α-tubulin to 
annotate mitotic spindle assembly and disassembly (Fig. 3a and Supplementary 
Movie 5), and to movies from cells expressing GalT-EGFP to study mitotic 
breakdown and reassembly of the Golgi apparatus (Fig. 3b, and Supplementary Movie 
6). We trained classifiers for six (α-tubulin), or five (GalT) distinct morphology 
classes. The mean accuracy of object class predictions was 96.5% for mEGFP-α-
tubulin, and 97.3% for GalT-EGFP (5-fold cross-validation, computational versus 
visual scoring). This yielded 55% (α-tubulin), or 38% (GalT) completely error-free 
trajectories. By hidden Markov model error correction, the accuracy increased to 89% 
completely error-free trajectories for α-tubulin (Fig. 3d and Supplementary Movie 7), 
and 90% for GalT (Fig. 3e and Supplementary Movie 8; n = 100 for both assays; 
corresponding H2B-mCherry annotations are shown in Fig. 3g, h).   
To apply our methods to non-mitotic cellular dynamics, we next annotated the timing 
of S-phase progression. We imaged a HeLa cell line stably expressing H2B-mCherry 
and EGFP-PCNA, a marker for DNA replication foci, which visualizes a 
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characteristic pattern of morphology changes during S-phase progression (Fig. 3c and 
Supplementary Movie 9). We trained classifiers for six distinct PCNA morphology 
classes, and established a hidden Markov model for error correction. This yielded 
98.2% correctly annotated objects and 90% completely error-free trajectories (n = 100 
trajectories containing 15,000 objects; Fig. 3f and Supplementary Movie 10, see Fig. 
3i for H2B annotations of same cells). The high performance in this diverse set of 
assays demonstrates a generic applicability of our computational methods. 
 
Quantitative phenotyping and kinetic measurements 
Our methods were designed for the detection of timing phenotypes. We therefore 
established perturbation conditions that are known to delay or shorten particular 
stages of mitosis. First, we used the microtubule-depolymerizing drug Nocodazol, 
which arrests cells in prometaphase by permanent activation of the spindle checkpoint 
(Fig. 4a; Supplementary Movie 11). This was reliably detected by our computational 
tools (96.2% completely error-free annotated trajectories, n = 154; Fig. 4b).  
Next, we depleted the essential spindle checkpoint component Mad2 by RNAi, which 
is known to accelerate the timing from mitotic entry until anaphase onset in HeLa 
cells by about two-fold26 (Fig. 4a; Supplementary Movie 12). We evaluated the 
accuracy of automated timing measurements, scoring the time from prometaphase 
until anaphase onset based on the chromatin marker (cells that did not segregate 
chromosomes were omitted). Automated measurements of 47.2 ± 20.0 min (mean ± 
s.d.; n = 195) in control cells did not significantly differ from manual annotation of 
the same dataset (48.5 ± 18.0 min; two-sided Mann-Whitney-Wilcoxon test: p = 
0.12). Automated timing measurements in Mad2 RNAi cells demonstrated mitotic 
acceleration (13.0 ± 3.6 min), again matching well measurements by manual 
annotation (12.4 ± 3.4 min; two-sided Mann-Whitney-Wilcoxon test: p = 0.23). As 
expected from the known biological function of Mad2, the mitotic acceleration in 
Mad2 RNAi cells was mainly due to a shortened metaphase stage (1.6 ± 1.1 min in 
Mad2 RNAi cells; 36.5 ± 16.6 min in control; Fig. 4b).  
Simultaneous measurements of morphological dynamics and the state of regulatory 
factors provide a powerful approach for mechanistic dissection of perturbation 
phenotypes. Here, we combined the annotation of mitotic stages with kinetic 
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measurements of Securin degradation, which is required for anaphase initiation27 (Fig. 
4a; Supplementary Movies 11-13). In the normalized degradation kinetic profiles 
(Fig. 4c), we found that the Securin-mEGFP degradation in control cells initiated 
briefly before anaphase (compare Fig. 4b and c), consistent with spindle checkpoint 
inactivation at this stage. In nocodazol-arrested cells, almost Securin-mEGFP 
remained stable within the measurement period of 138 min, consistent with an 
efficient and permanent activation of the spindle checkpoint. Securin-mEGFP 
degradation in Mad2 RNAi cells initiated directly after mitotic entry, at a stage where 
chromosomes were still in prometaphase configuration, indicating that the anaphase-
promoting complex was activated before complete chromosome congression, as 
expected for a compromised spindle checkpoint function. In conclusion, these 
experiments demonstrate accurate timing phenotype annotation in RNAi- and drug-
perturbed cells.  
 
RNAi screen for mitotic exit regulators 
To test the sensitivity and performance of our computational methods in a high-
throughput application, we performed a screen for regulators of mitotic exit. 
Specifically, we aimed to identify regulators of post-anaphase stages of mitosis, for 
which RNAi phenotypes have not been reported so far. Mitotic exit control is well 
understood in budding yeast, yet it is unclear if homologues of the yeast factors also 
control mitotic exit in higher eukaryotes28. We therefore designed a library of 283 
siRNA targeting 93 candidate regulators, including all known human genes with 
homology to budding yeast mitotic exit regulators and some additional genes known 
to be involved in mitotic regulation (see Supplementary Table 2). As an assay for 
mitotic exit timing, we scored the timing from anaphase onset, based on the chromatin 
marker H2B-mRFP, until postmitotic nuclear envelope reassembly, based on the 
nuclear import substrate IBB-EGFP (Fig. 5a; Supplementary Movie 14).  
For solid-state transfection of siRNAs into HeLa cells, we used a high-density 
transfection array with 300 spots of different siRNA transfection solutions printed to 
the glass surface of a chambered coverslip7. We seeded the cells onto this array and 
20 h later started parallel imaging of 108 movies per experiment, for a total duration 
of 46 h and with 3.7 min time resolution. We automatically annotated the mean 
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mitotic exit timing per experimental condition within the 1.6 TeraByte data 
containing 646’754 images and 16’314 mitotic events. Only one siRNA delayed 
mitotic exit above a z-score threshold of 3.0 (Fig. 5b, Supplementary Fig. 8a; 6.8 ± 
2.0 min mean ± sd; n = 50 mitotic events). This oligo depleted the anaphase 
promoting complex co-activator Cdc20, as validated by Western Blotting 
(Supplementary Fig. 8b). The specificity of the phenotype was confirmed in two 
additional replicas with standard liquid phase transfection, and with an additional 
siRNA (Fig. 5c).  
To test if Cdc20 was required for other cellular reorganization processes during 
mitotic exit, we assayed chromosome decondensation and mitotic spindle 
disassembly. High resolution confocal time-lapse imaging of cells co-expressing 
H2B-mCherry and mEGFP-α-tubulin (Fig. 5d, e, and Supplementary Movies 15 and 
16) showed that 100% (n = 30) of control cells started chromosome decondensation 
within 14 minutes after chromosome segregation, whereas only 54% (n = 36) did so 
after Cdc20 depletion. 31% (n = 36) of Cdc20-depleted cells started kinetochore fiber 
spindle disassembly 7 minutes post anaphase onset, in contrast to 87% (n = 30) in 
control cells. These data suggest a requirement of Cdc20 for various cellular 
processes leading to postmitotic reassembly of interphase cells. This is unexpected 
given that Cdc20 has so far been thought to act mainly at pre-anaphase stages of 




In this study, we present CellCognition, a computational framework for time-resolved 
single-cell assays in high-throughput imaging applications. Building on existing 
machine learning methodologies, the design of a generic workflow for annotation of 
morphological dynamics faced two main challenges. First, the classification noise at 
continuous morphology stage transitions impairs coherent trajectory annotation. 
Second, some biologically distinct classes appear morphologically similar, which 
leads to high classification confusion. By hidden Markov modeling, our methods 
efficiently correct both types of errors based on the temporal context. The hidden 
Markov models are learned individually for each experimental condition, without any 
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human supervision. This allows the software to automatically adapt the error 
correction scheme to phenotypic deviations.  
Biological a priori knowledge to suppress state transitions that are assumed to be 
impossible can also be used to improve annotation accuracy11, 12. Such explicit error 
correction schemes cannot be applied to new markers or assay systems without 
adaptation, and they may not apply to phenotypes with potentially altered stage 
progression. We find that the gain in accuracy by biological a priori constraints on the 
temporal progression is only minor. Our hidden Markov implementation models time 
series analysis in a high dimensional feature space with an intrinsic class-discriminant 
dimensionality reduction. This preserves context-specific structures, in contrast to 
principle component analysis as used in 12, 30, which may explain the large gain in 
accuracy compared to the previous implementations (see Supplementary Tables 3 and 
4). Compared to the models by 11, 12, our model is the only one able to handle arbitrary 
relationships between phenotypic cell classes, providing a powerful and generic 
solution for time-resolved cellular phenotyping. 
Using a variety of different structural markers, we demonstrate that our analysis 
methods can be used for a broad range of biological assays. We are not aware of any 
constraints that would preclude the use of our methods in other biological context, 
e.g., apoptosis or cellular differentiation. However, the texture and shape features 
implemented into our software do not enable assays relying on absolute object counts, 
for example in centrosome duplication assays. Also, assays scoring rapid intracellular 
dynamics would require integration of motion feature extraction methods into our 
published software source code.  
Supervised machine learning as in this study requires user-defined morphology 
classes. It is therefore not possible to detect aberrant phenotypic morphologies that do 
not occur in the control conditions used for annotating the classifier training set. This 
limitation may be overcome in future studies by implementing unsupervised machine 
learning methods for the analysis of image time series. 
In conclusion, we present a powerful computational strategy for high-throughput 
phenotyping of single cell dynamics. Our methods are integrated into the platform-
independent software package CellCognition, with graphical user interface and 
supporting high-throughput batch processing on computer clusters. CellCognition is 
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published as open source software (current version 1.0.7 in Supplementary Software), 
along with high quality reference image data on http://www.cellcognition.org/. With 
the increased availability of live cell screening microscopes, we anticipate that time-
resolved imaging assays will soon dominate a significant fraction of high content 
screening and systems biology applications. 
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Methods 
 
Cell culture, RNAi and cell transfection arrays, and Western Blotting  
HeLa ‘Kyoto’ cells were cultured in DMEM (Gibco) supplemented with 10% fetal 
calf serum (PAA Laboratories) and 1% Penicillin/Streptomycin (Invitrogen), and 
grown on LabTek chambered coverslips (Nunc) for live microscopy. All experiments 
were performed with monoclonal cell lines stably expressing combinations of the 
fluorescent markers as indicated throughout the manuscript. Live imaging was in 
DMEM containing 10% fetal calf serum and 1% Penicillin/Streptomycin, but without 
phenolred and riboflavin to reduce autofluorescence of the medium. Cell transfection 
arrays for live cell RNAi screening were produced and used as described in 7, 31. All 
other RNAi interference experiments were performed using single RNAi duplexes 
(Qiagen) that were liquid phase transfected with either Oligofectamine (Invitrogen) or 
HiPerfect (Qiagen) as transfection reagent according to the manufacturers protocols. 
Final siRNA concentrations were 50 nM for Oligofectamine or 10 nM for HiPerfect. 
Cdc20 siRNA validation oligos were obtained from Qiagen with the following target 
sequences: AACCTTGTGGATTGGAGTTCT (Cdc20_1), 
CACCACCATGATGTTCGGGTA (Cdc20_2). Total HeLa cell lysates for SDS/Page 
analysis were prepared according to standard procedures. Rabbit-anti-human Cdc20 
antibody (diluted 1:5000) was from Bethyl laboratories. 
 
Fluorescent reporter plasmid constructs  
For efficient generation of cell lines stably expressing fluorescently tagged marker 
proteins, the genes were subcloned into pIRES-puro2 and pIRES-neo3 vectors 
(Clontech) that allow expression of resistance genes and tagged proteins from a single 
transcript. For details on the plasmids, see Supplementary Table 5. 
 
 
Stably expressing cell lines 
For generation of stably expressing cell lines, HeLa Kyoto cells were first transiently 
transfected using FuGENE6 (Roche) following the manufacturer’s instructions. Cells 
were then seeded to clonal density and grown in culture medium supplemented with 
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500 µg/ml Geneticin (Invitrogen) and/or 0.5µg/ml Puromycin (Merck/Calbiochem) 
for three weeks. Individual colonies of resistant cells were picked, expanded, and 
validated for homogeneous expression levels and correct sub-cellular localization of 
fluorescent proteins. All cell lines used in this study had a normal morphology and 
cell cycle progression as compared to the maternal line. For details on the stable cell 
lines, see Supplementary Table 6. 
 
Live microscopy 
Automated microscopy with reflection-based laser auto focus was performed on a 
Molecular Devices ImageXpressMicro screening microscope equipped with 10x 0.5 
N.A. and 20x 0.8. N.A. S Fluor dry objectives (Nikon), and recorded as 2D time-
series. The microscope was controlled by in-house developed Metamorph macros 
(PlateScan software package, available at 
http://www.bc.biol.ethz.ch/people/groups/gerlichd). Cells were maintained in a 
microscope stage incubator at 37 ºC in humidified atmosphere of 5% CO2 throughout 
the entire experiment.  We adjusted illumination conditions such that cell death rate 
was below 5% in untreated control cells14. Confocal microscopy was performed on a 
customized Zeiss LSM 510 Axiovert microscope using a 63x, 1.4 N.A. Oil Plan-
Apochromat objective (Zeiss). The microscope was equipped with piezo focus drives 
(piezosystemjena), custom-designed filters (Chroma), and EMBL incubation chamber 
(European Molecular Biology Laboratory), providing a humidified atmosphere at 
37°C with 5% CO2. 
 
Image analysis 
Cell nuclei were detected by local adaptive thresholding7, which is robust towards 
variable expression levels of the fluorescent chromatin marker in individual cells, and 
inhomogeneous illumination typical for wide-field microscopy. To improve 
segmentation accuracy, we implemented a split-and-merge approach. First, we split 
objects containing directly adjacent nuclei, using watershed transformation based on 
object contours. In some cases, this incorrectly split single objects. Thus we 
implemented object merging based on a priori definition of size and circularity 
criteria16. Regions of interest for the secondary marker were derived by region 
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growing of the chromatin segmentation to a fixed size, but constrained by regions of 
neighboring cells. Depending on the marker, we defined nuclear, cytoplasmic, or total 
cellular areas. This segmentation strategy turned out to be more precise than direct 
segmentation in the secondary channel, as many secondary markers dramatically 
changed in intensity levels or pattern throughout the time course of the experiment. 
Texture and shape features17, 18  (see Supplementary Table 1) were extracted from the 
two channels and all regions individually. For secondary region classification, only 
texture features were used since the shape information only depended on the 
chromatin segmentation. 
Samples for morphology classes were manually annotated on the original images 
overlaid with the segmentation contours, to establish a training set for supervised 
classification. Support vector classification with radial-based kernel and probability 
estimates32 was then computed with libSVM. Classification performance was 
calculated with five-fold cross-validation. Samples and feature plots for all classifiers 
used in this study can be accessed online through a web browser interface (see 
resource section). 
Tracking cells over time was achieved by a constrained nearest-neighbor approach 
based on the Euclidian distance between objects21. Since tracks might be lost due to 
segmentation errors or migration of cells into the field of view the tracking must be 
able to create new tracks for all objects without incoming edges. To detect cell 
division events, or potential cell-to-cell fusion events, the tracking algorithm needed 
to support both splitting and merging. This yielded a hierarchical directed graph of 
isolated tracks for each cell over time. Tracking errors resulted mostly from 
segmentation errors and lead to wrong edges between the cell tracks. Secondary 
objects are tracked indirectly by the primary objects associated with them. Mitotic 
motifs were detected in this graph structure by the transition from prophase to 
prometaphase. Sub-graphs (mitotic trajectories) were extracted by considering a pre-
defined number of frames preceding and following this mitotic motif, resulting in 
synchronized mitotic trajectories of equal length, as displayed in the figures.  
 
Hidden Markov model and statistical analysis 
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A hidden Markov model λ is defined as λ = (X, A, Y, B, π), where X is the set of 
hidden states, A is a matrix of transition probabilities from one state to another, Y is 
the set of observable variables per state, B is a matrix of observation probabilities 
storing the probability of observation k being produced from state j (also termed 
emission or observation probability), and π is a vector of probabilities of the initial 
state (first time point) in the trajectory.  
The hidden states X are the true cellular stages expressed by the class labels (8 classes 
for fluorescent H2B, see Fig. 1b). The hidden Markov model is learned by maximum 
likelihood estimates from the aligned trajectories of estimated prediction probabilities 
of the support vector machine, which is a three-dimensional array over trajectories, 
time points, and classes. Transition probabilities A are learned from the prediction 
probabilities along the trajectories on the underlying graph structure. In a free model 
all transitions between morphology classes were allowed (Fig. 2c). In a constrained 
model some transitions were suppressed based on biological a priori knowledge 
(transition probabilities were set to 0 for edges missing in the graph; Supplementary 
Fig. 6a). For the initial probabilities π the prediction probabilities of all trajectories at 
the first time point are considered. The observables Y are the class labels. The 
observation probabilities were either set to an error rate of 0.1%, or derived from the 
confusion matrix of support vector machine training. 
Using the Viterbi algorithm, each trajectory was corrected based on its sequence of 
support vector machine probability estimates and the trained hidden Markov model 
for a given experimental condition (decode problem). This correction scheme was 
calculated individually for each marker and experimental perturbation condition. 
To detect the onset of nuclear envelope breakdown and nuclear envelope reformation 
the time series of IBB-EGFP intensity ratios of individual cells were analyzed. We 
computed the ratio by a shrunken area of the chromatin object and a ring around. The 
onset was defined as the time point where the ratio was 1.5 fold increased above the 
ratio at the time point of chromosome segregation.  
For data normalization of Fig. 5b we computed the z-scores of mitotic exit timing for 
all siRNA conditions (mean over all values of one condition). The z-score was 
computed by the mean of negative controls and the standard deviation of the entire 
data set.  
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Implementation and performance 
The basic image processing was implemented in C++ using VIGRA 
(http://hci.iwr.uni-heidelberg.de/vigra) and in house-developed extensions. The C++ 
code was then wrapped for Python, which is a programming language particularly 
well suited for handling complex data structures and integration of external modules. 
Statistical analysis and plots were performed with the R-project (http://www.r-
project.org). The entire software package is platform-independent, and was compiled 
for Mac OS X and Windows environments. 
Computation of each movie required 4-20 s per image and processor node, consuming 
500-1500 MB RAM, depending of the number of frames and objects per frame. As an 
example, a single movie of Fig. 2 with 206 frames and ~37,000 objects required a 
total processing time of 34 min on a single processor node. For high-throughput 
analysis, we implemented distributed computing on a farm of desktop computers 
(four MacPro 2.2GHz, 28 cores total). 
 
Software and data resources 
CecogAnalyzer is a platform-independent graphical user interface, which covers the 
entire workflow presented in this paper. The software is publicly available in source 
and binary versions and was tested on MacOS X Leopard/SnowLeopard and 
Windows XP/7. We use a subversion repository for concurrent software development 
by remote contributors, and tracking of software changes. Our website is based on the 
project management tool TRAC (http://trac.edgewall.org/), which allows co-
ordination of this open-source project by milestones, tickets, wiki pages and browsing 
of code changes.  
The software, a subset of raw images presented here, the classifiers and parameters 
used for generating the figures are available online at http://www.cellcognition.org. 
The classifiers data sets consisting of annotated samples and extracted features are 
interactively visualized by Adobe Flex and can be browsed online at 
http://flex.cellcognition.org. 
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The MetaMorph journals developed for fast and robust acquisition of the time-lapse 
experiments presented here are available on our group website: 
http://www.bc.biol.ethz.ch/people/groups/gerlichd. 
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Figure legends 
 
Figure 1. Supervised machine learning and classification of morphologies. (a) 
Confocal images of live HeLa cells stably expressing a chromatin marker (H2B-
mCherry), together with GalT-EGFP to visualize the Golgi apparatus, with mEGFP-
α-tubulin, or with the replication factory marker EGFP-PCNA. The images show 
maximum intensity projections of five z-sections. (b) Live imaging of HeLa cells 
expressing H2B-mCherry at different cell cycle stages, or apoptosis (2D time series 
imaged with wide field epifluorescence 20x dry objective, see Supplementary Movie 
1). The color scheme relates to H2B-mCherry morphology classifications of 
subsequent figures. (c) Object detection (contours) and classification (colors) of 
cellular morphologies corresponding to predefined mitotic stages as shown in (b). 
Cells were tracked over time (arrows). See Supplementary Movie 2. (d) Classification 
performance of support vector machines with radial basis functions. The confusion 
matrix displays the matching of human versus machine annotation, identical 
annotations are on the diagonal. (e) Automated annotation of cell trajectories over 
time by the workflow shown in (c). 80 randomly selected trajectories (rows) over 40 
time frames (columns) are displayed (time-lapse: 4.6 min). Colors refer to 
morphology classes as labeled in (b). Tick marks indicate sampled time points. 
Mitotic events are rare, and the trajectories contain many single frames of mitotic 
annotations, likely due to classification errors. Scale bars: 10 µm. 
 
Figure 2. Hidden Markov modeling of progression through morphology stages. 
(a) Automated extraction of mitotic events. Cells were synchronized in silico to the 
prophase - prometaphase transition. The plot displays a random selection of 100 
mitotic events (from a total set of 172 mitotic events out of 8 movies; time-lapse: 4.6 
min; see Supplementary Movie 1). Predicted morphology classes were color-labeled 
as in Fig. 1b. Asterisks: classification errors. Black frame indicates region of interest 
displayed by contour overlays on image data. For complete data, see Supplementary 
Movie 3. (b) Single cell and corresponding trajectory of class labels. Asterisks: 
classification errors. (c) Graph for all possible transitions between classes. Node 0 is 
start node, all other nodes are color-labeled as in Fig. 1b. (d) Learned class transition 
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probabilities based on the trajectories shown in (a). Normalization of probabilities 
was per node. (e) Trellis diagram showing all class prediction estimates for the cell 
shown in (c). Vertical columns correspond to single time points, aligned to the images 
in (c). Rows correspond to morphology classes, labeled as in Fig. 1b. Probability 
estimates derived from the support vector machine are coded by size. The Viterbi 
algorithm was used to decode the overall most likely sequence (thick black line). Thin 
black lines indicate the most likely preceding state of a label at each given time point. 
(f) Error correction as in (e) was performed for all trajectories shown in (a). See also 
Supplementary Fig. 3 and Supplementary Movie 4. Scale bars: 10 µm. 
 
Figure 3. Automated annotation of mitotic spindle and Golgi dynamics, and 
replication factory patterns during S-phase progression. (a) Live imaging of 
mitotic spindle dynamics of a cell expressing H2B-mCherry and mEGFP-α-tubulin; 
20x objective; 4.6 min time-lapse; see Supplementary Movie 5. Automated hidden 
Markov model-corrected classification of spindle morphology, was color labeled as 
indicated. (b) Live imaging of mitotic Golgi dynamics in a cell line expressing H2B-
mCherry and GalT-EGFP; 10x objective; 2.8 min time-lapse; see Supplementary 
Movie 6. Colors indicate automated hidden Markov model-corrected annotation of 
Golgi morphologies. (c) Live imaging of DNA replication factory dynamics in a cell 
line expressing H2B-mCherry and PCNA-EGFP; 10x objective; 5.9 min time-lapse; 
see Supplementary Movie 9. Colors indicate automated hidden Markov model-
corrected annotation of S-phase progression based on PCNA morphology. (d) 
Automated annotation of a high-throughput imaging dataset. 100 randomly selected 
mitotic events were derived and in silico synchronized to the prophase - prometaphase 
transition based on the H2B-mCherry annotation (see Fig. 2). The secondary channel 
annotation was calculated independently from the H2B-mCherry channel, as indicated 
in (a). See Supplementary Movie 7. (e) Automated annotation of Golgi dynamics, 
processed as in (d). See Supplementary Movie 8. (f) Automated annotation of S-phase 
progression. Cells were in silico synchronized to the G1 – early S transition based on 
the EGFP-PCNA classification.  See Supplementary Movie 10. (g-i) Hidden Markov 
model-corrected annotations of H2B-mCherry morphologies for the cells shown in (d-
f). Colors label classes as in Fig. 1b. Scale bars: 10 µm. 
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Figure 4. Timing phenotypes and kinetic measurements. (a) Mitotic progression 
assayed by H2B-mCherry morphology, and degradation of Securin-mEGFP. 
Examples are shown for untreated control cell (larger region of original data shown in 
Supplementary Movie 13), a cell with Mad2 RNAi-inactivated spindle checkpoint 
(siMad2; larger region of original data shown in Supplementary Movie 12), and a cell 
arrested in prometaphase by a Nocodazol (Noc; larger region of original data shown 
in Supplementary Movie 11). Time-lapse: 2.7 min. (b) Automated classification of 
mitotic stage progression as in Fig. 2f for the three experimental conditions shown in 
(a). (c) Securin-mEGFP degradation kinetics for the same cells shown in (b). 
Normalization was per trajectory to the first prometaphase frame. Scale bar: 10 µm. 
 
Figure 5. RNAi screen for mitotic exit regulators. (a) Assay for mitotic exit timing. 
Live imaging of a cell line expressing H2B-mCherry and IBB-EGFP. The timing 
from anaphase onset (red bar) until onset of nuclear accumulation of IBB-EGFP 
(green bar) was used to define mitotic exit timing (arrow). Time is in min:s. Larger 
region of original data shown in Supplementary Movie 14. (b) Mitotic exit timing in 
an RNAi screen for 300 different RNAi conditions. 108 movies of different siRNA 
transfections were recorded in parallel over 46 h, to collect the entire dataset in four 
experiments. Time-lapse: 3.7 min; see Supplementary Movie 14. Each point in the 
graph indicates the z-score for one siRNA (for calculation of z-scores, see methods). 
Dashed lines indicate z-score threshold, solid line indicates mean of the entire dataset. 
Each gene was targeted by three different siRNA oligos (For full list of oligos, see 
Supplementary Table 1). (c) Cumulative percentage of cells exiting mitosis after onset 
of chromosome segregation (t = 0 min). The curves represent all mitotic events from 
two experimental replica. Cells were transfected in liquid phase with two different 
siRNA targeting Cdc20, or a non-targeting oligo for control, as indicated in the 
legend. (d) Confocal time-lapse imaging of a cell stably expressing H2B-mCherry 
and mEGFP-α-tubulin. Time is in min:s, maximum intensity projection of five z-
slices. See Supplementary Movie 15. (e) Confocal imaging as in (a) for a Cdc20 
RNAi cell. See Supplementary Movie 16. Scale bars: 10 µm.  
 
 
  25 
References 
1. Conrad, C. & Gerlich, D.W. Automated microscopy for high-content RNAi 
screening. J Cell Biol 188, 453-461 (2010). 
2. Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged 
chromosomes to allow accumulation of repair proteins. Cell 136, 435-446 
(2009). 
3. Collinet, C. et al. Systems survey of endocytosis by multiparametric image 
analysis. Nature 464, 243-249 (2010). 
4. Sonnichsen, B. et al. Full-genome RNAi profiling of early embryogenesis in 
Caenorhabditis elegans. Nature 434, 462-469 (2005). 
5. Goshima, G. et al. Genes required for mitotic spindle assembly in Drosophila 
S2 cells. Science 316, 417-421 (2007). 
6. Neumann, B. et al. Phenotypic profiling of the human genome by time-lapse 
microscopy reveals cell division genes. Nature 464, 721-727 (2010). 
7. Neumann, B. et al. High-throughput RNAi screening by time-lapse imaging of 
live human cells. Nat Methods 3, 385-390 (2006). 
8. Loo, L.H., Wu, L.F. & Altschuler, S.J. Image-based multivariate profiling of 
drug responses from single cells. Nat Methods 4, 445-453 (2007). 
9. Conrad, C. et al. Automatic identification of subcellular phenotypes on human 
cell arrays. Genome Res 14, 1130-1136 (2004). 
10. Glory, E. & Murphy, R.F. Automated subcellular location determination and 
high-throughput microscopy. Dev Cell 12, 7-16 (2007). 
11. Harder, N. et al. Automatic analysis of dividing cells in live cell movies to 
detect mitotic delays and correlate phenotypes in time. Genome Res (2009). 
12. Zhou, X., Li, F., Yan, J. & Wong, S.T. A novel cell segmentation method and 
cell phase identification using Markov model. IEEE Trans Inf Technol Biomed 
13, 152-157 (2009). 
13. Gerlich, D. & Ellenberg, J. 4D imaging to assay complex dynamics in live 
specimens. Nat Cell Biol. 5, S14-S19 (2003). 
14. Schmitz, M.H. & Gerlich, D.W. Automated live microscopy to study mitotic 
gene function in fluorescent reporter cell lines. Methods Mol Biol 545, 113-
134 (2009). 
15. Boland, M.V. & Murphy, R.F. … the patterns of all major subcellular 
structures in fluorescence microscope images of HeLa cells. Bioinformatics 
(2001). 
16. Wahlby, C., Sintorn, I.M., Erlandsson, F. & Borgefors, G. Combining 
intensity, edge and shape information for 2D and 3D segmentation of cell 
nuclei in tissue …. Journal of Microscopy (2004). 
17. Walker, R. & Jackway, P. Statistical geometric features-extensions for 
cytological textureanalysis. Pattern Recognition, 1996., Proceedings of the 
13th International Conference on 2 (1996). 
18. Haralick, R., Dinstein & Shanmugam Textural features for image 
classification. IEEE Transactions on Systems (1973). 
19. Boser, B.E., Guyon, I. & Vapnik, V. A training algorithm for optimal margin 
classifiers. COLT '92: Proceedings of the fifth annual workshop on 
Computational learning theory (1992). 
20. Wang, M. et al. in Bioinformatics, Vol. 24 94-101 (2008). 
  26 
21. Chen, X., Zhou, X. & Wong, S.T. Automated segmentation, classification, and 
tracking of cancer cell nuclei in time-lapse microscopy. Biomedical 
Engineering, IEEE Transactions on 53, 762-766 (2006). 
22. Durbin, R., R. Eddy, S., Krogh, A. & Mitchison, G. Biological sequence 
analysis: probabilistic models of proteins and nucleic acids ‎. 356 (1998). 
23. Viterbi, A. Error bounds for convolutional codes and an asymptotically 
optimum decoding algorithm. Information Theory, IEEE Transactions on 13, 
260 - 269 (1967). 
24. Baum, L.E., Petrie, T., Soules, G. & Weiss, N. A maximization technique 
occurring in the statistical analysis of probabilistic functions of Markov 
chains. Ann. Math. Statist 41, 164-171 (1970). 
25. Dempster, A.P., Laird, N.M. & Rubin, D.B. Maximum likelihood from 
incomplete data via the EM algorithm. Journal of the Royal Statistical Society. 
Series B 39, 1-3 (1977). 
26. Meraldi, P., Draviam, V.M. & Sorger, P.K. Timing and checkpoints in the 
regulation of mitotic progression. Dev Cell 7, 45-60 (2004). 
27. Hagting, A. et al. Human securin proteolysis is controlled by the spindle 
checkpoint and reveals when the APC/C switches from activation by Cdc20 to 
Cdh1. J Cell Biol 157, 1125-1137 (2002). 
28. Bollen, M., Gerlich, D.W. & Lesage, B. Mitotic phosphatases: from entry 
guards to exit guides. Trends Cell Biol (2009). 
29. Wolthuis, R. et al. Cdc20 and Cks direct the spindle checkpoint-independent 
destruction of cyclin A. Mol Cell 30, 290-302 (2008). 
30. Wang, M., Zhou, X., King, R.W. & Wong, S.T. Context based mixture model 
for cell phase identification in automated fluorescence microscopy. BMC 
Bioinformatics 8, 32 (2007). 
31. Erfle, H. et al. Reverse transfection on cell arrays for high content screening 
microscopy. Nat Protoc 2, 392-399 (2007). 
32. Wu, T.F., Lin, C.J. & Weng, R.C. Probability estimates for multi-class 
classification by pairwise coupling. The Journal of Machine Learning 
Research (2004). 
33. Snapp, E.L. et al. Formation of stacked ER cisternae by low affinity protein 
interactions. J Cell Biol 163, 257-269 (2003). 
34. Dultz, E. et al. Systematic kinetic analysis of mitotic dis- and reassembly of 
the nuclear pore in living cells. J Cell Biol 180, 857-865 (2008). 
35. Schaub, B.E., Berger, B., Berger, E.G. & Rohrer, J. Transition of 
galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is 
signal mediated. Mol Biol Cell 17, 5153-5162 (2006). 
36. Leonhardt, H. et al. Dynamics of DNA replication factories in living cells. J 
Cell Biol 149, 271-280. (2000). 
37. Steigemann, P. et al. Aurora B-mediated abscission checkpoint protects 








H2B GalT H2B α-Tubulin H2B PCNA



















































































































































































































-93 0 775Time [min]































































































































0:00 7:23 14:27 21:31 28:37 35:42 42:47 49:52-7:23-14:27
0-46 133










0-46 133 0-46 133 0-46 133
0% random. training data 10% 20% 50%




















94.5% overall accuracy 91.5% 90.6% 87.%
Effect of annotation errors on support 
vector machine accuracy
(a) Annotation of trajectories shown in Fig. 2a 
using support vector machine classifiers trained 
with partially randomized training data. A 
fraction of training objects was assigned with 
random class labels (percentage as indicated in 
the header line; uniform distribution; 8 classes). 
Support vector machines were trained by grid 
search and 5-fold cross-validation. The overall 
prediction accuracy (correct predictions / total 
predictions) was measured by comparison with 
original error-free manual annotation.
(b) Plot visualizing the overall prediction 
accuracy relative to the percentage of rand-
omized training data as in (a). Data-points show 
the mean and error-bars the standard deviation 
of 8 repetitions.

































Feature visualization in the subspace of the first two principal components
Data points visualize the first two principal components computed from 186 features and 
689 manually annotated objects of the support vector machine classifier shown in Fig. 1d 
(color labels indicate morphology classes). Each object corresponds to a single H2B-
labeled cell of the training set. Classes form overlapping clusters, which prevents perfect 













































































Annotation of the fastest and slowest trajectories
(a) Trajectories of the 10% cells progressing fastest through mitosis, from the cells shown in Fig. 2. Contour colors 
indicate the class label predictions by the support vector machine (upper row; w/o correction; see Fig. 2a), and the 
hidden Markov model-corrected class labels (lower row; HMM correction; see Fig. 2f).
(b) Trajectories of the 10% cells progressing slowest through mitosis as in (a).
94.5% overall accuracy 86.5% 78.1% 53.9%







































Effect of support vector machine class 
prediction noise on hidden Markov model 
error correction
(a) Support vector machine prediction probabili-
ties (8-vector; color corresponds to class label 
with highest probability) of Fig. 2a were randomly 
sampled and replaced by random numbers 
(uniform distribution; sum 1.0). Fractions of the 
100x40 objects were randomized from 0% to 
100% in 10% steps and 8 repetitions. The overall 
prediction accuracy (correct predictions / total 
predictions) was measured based on the manual 
annotation. Trajectory panels are shown for 0%, 
10%, 20%, and 50% randomized data w/o 
correction (upper panel) and with HMM correction 
(lower panel). 
(b) A hidden Markov model was trained on the 
partially randomized data shown in (a) and errors 
corrected on the randomized trajectories.
(c) Plot visualizing the overall prediction accuracy 
w/o correction (red line) and with hidden Markov 
model correction (green line) relative to the 
percentage of randomized data. Average and 
standard deviation of 8 repetitions shown.































































4.6 min (40 frames) 9.2 (20) 13.8 (14) 27.6 (7)


























94.5% overall accuracy 94.1% 94.6% 94.0%
99.4% overall accuracy 96.7% 97.6% 97.4%
Effect of different time-lapse intervals on 
hidden Markov error correction
(a) Every nth frame (from 1 to 6) of the trajecto-
ries from Fig. 2a was selected to simulate 
different time-lapse intervals (4.6 min to 27.6 
min). The overall accuracy was measured by 
comparison with manual annotation. 
(b) Same data and procedure as in (a) but with 
hidden Markov model trained on and applied to 
the subsampled trajectories.
(c) Plot visualizing the overall accuracy w/o 
correction (red line) and with hidden Markov 
model correction (green line) for differently 
sampled time-lapse. Note: A higher time-lapse 
might decrease tracking accuracy, which is not 
























 Hidden Markov model error correction based on biological a priori knowledge
(a) Class transitions were constrained to the forward direction of 3 consecutive frames, and apoptosis was defined 
as terminal state. 
(b) Learned stage transition probabilities for the constrained model based on the same data shown in Fig. 2A. 



















































Strategy for annotation of multi-channel assays.
(a) Single frame of a movie from a cell expressing H2B-mCherry and mEGFP-a-tubulin.
(b) Segmentation of secondary channel. Cells were first segmented by the H2B-mCherry (red 
contours), which was dilated to derive cytoplasmic regions (green contours).
(c) Workflow schematic for processing of two-channel experiments. The training of the classifier 
























0:00 3:06 6:12 9:18 12:24 15:30 18:36 21:42-3:06-6:12
Cdc20 RNAi phenotype
(a) Mitotic exit timing in Cdc20 RNAi cell expressing H2B-mCherry and IBB-EGFP. The arrow indicates timing 
from anaphase onset (red bar) until onset of nuclear accumulation of IBB-EGFP (green bar). Cells were 
imaged as 2D time series with widefield epifluorescence 10x dry objective; time is in min:s. Bar: 10 μm
(b) Validation of Cdc20 RNAi. Western Blotting of whole cell lysates 60 h after transfection of two different 
siRNA oligos targeting Cdc20, or a non-silencing siRNA oligo for negative control. The unspecific band 
detected by the anti-Cdc20 antibody served as a loading control.
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Suppl. Table 2. siRNA oligos used for RNAi screening
Gene HUGO Symbol Full Gene Name Entrez Gene ID RefSeq Accession Number Ambion siRNA ID Sense siRNA Sequence Antisense siRNA Sequence
1-Sep septin 1 1731 NM_052838, 35578 GGAUGCAGAGAUGAAGGAAtt UUCCUUCAUCUCUGCAUCCtg
1-Sep septin 1 1731 NM_052838, 35491 GGAAGAGGAGAUCCACAUCtt GAUGUGGAUCUCCUCUUCCtt
1-Sep septin 1 1731 NM_052838, 35399 GGAGCAAUUUGAGCAGUACtt GUACUGCUCAAAUUGCUCCtc
3-Sep septin 3 55964 NM_019106,NM_145733,NM_145734, 38214 GGAGCUUGAAGUAAAUGGCtt GCCAUUUACUUCAAGCUCCtt
3-Sep septin 3 55964 NM_019106,NM_145733,NM_145734, 38123 GGAAGAAACGCAUCCCUGAtt UCAGGGAUGCGUUUCUUCCtg
3-Sep septin 3 55964 NM_019106,NM_145733,NM_145734, 133703 GGGCCAAGCCCUUUUUAGUtt ACUAAAAAGGGCUUGGCCCtg
6-Sep septin 6 23157 NM 015129,NM 145799,NM 145800,NM 136765 GGCUAAAGCUCACGAUCGUtt ACGAUCGUGAGCUUUAGCCtc
6-Sep septin 6 23157 NM 015129,NM 145799,NM 145800,NM 136764 GCAACGUGAGGCUAAAGCUtt AGCUUUAGCCUCACGUUGCtc
6-Sep septin 6 23157 NM 015129,NM 145799,NM 145800,NM 136766 GCUCACGAUCGUUAGCACAtt UGUGCUAACGAUCGUGAGCtt
8-Sep septin 8 23176 XM_034872, 264717 CCUCCUUACUCACUAUAGUtt ACUAUAGUGAGUAAGGAGGtg
8-Sep septin 8 23176 XM_034872, 264716 CGCCAUACUUUUCCUAUAUtt AUAUAGGAAAAGUAUGGCGtt
8-Sep septin 8 23176 XM_034872, 264715 GGCAGAUGUUUGUCAACAAtt UUGUUGACAAACAUCUGCCtc
10-Sep septin 10 151011 NM_144710,NM_178584, 215107 CCUUGACAGCAAGGUAAACtt GUUUACCUUGCUGUCAAGGtt
10-Sep septin 10 151011 NM_144710,NM_178584, 37634 GGUGGAUGUGAAACAUGAAtt UUCAUGUUUCACAUCCACCtt
10-Sep septin 10 151011 NM_144710,NM_178584, 37539 GGCUAUAUGUAUAAGGUGGtt CCACCUUAUACAUAUAGCCtg
11-Sep septin 11 55752 NM_018243, 125139 CCUGUACUAAAUGCCUAAUtt AUUAGGCAUUUAGUACAGGtt
11-Sep septin 11 55752 NM_018243, 125138 GGUGUUCGGUUAAAAGCCAtt UGGCUUUUAACCGAACACCtg
11-Sep septin 11 55752 NM_018243, 125137 CGUUAAUGGACACUUUGUUtt AACAAAGUGUCCAUUAACGtg
ANLN anillin, actin binding protein (scraps homolog 54443 NM_018685, 132620 GGAAGCUACAUUCUGUUCCtt GGAACAGAAUGUAGCUUCCtg
ANLN anillin, actin binding protein (scraps homolog 54443 NM_018685, 132619 GCCUGGUACCGCUUGUUUAtt UAAACAAGCGGUACCAGGCtg
ANLN anillin, actin binding protein (scraps homolog 54443 NM_018685, 132621 GGUUUCACUGAAUGCGAAAtt UUUCGCAUUCAGUGAAACCtt
ARHGAP17 Rho GTPase activating protein 17 55114 NM_018054,NM_001006634, 26221 GGAUCAAGACAAAAAACUUtt AAGUUUUUUGUCUUGAUCCtg
ARHGAP17 Rho GTPase activating protein 17 55114 NM_018054,NM_001006634, 26127 GGUGGAGAUUCCCAACAUCtt GAUGUUGGGAAUCUCCACCtc
ARHGAP17 Rho GTPase activating protein 17 55114 NM_018054,NM_001006634, 26031 GGAGACACAAAAAACUGCCtt GGCAGUUUUUUGUGUCUCCtc
AURKB aurora kinase B 9212 NM_004217, 495 GGUGAUGGAGAAUAGCAGUtt ACUGCUAUUCUCCAUCACCtt
AURKB aurora kinase B 9212 NM_004217, 494 GGAGGAUCUACUUGAUUCUtt AGAAUCAAGUAGAUCCUCCtc
AURKB aurora kinase B 9212 NM_004217, 493 GGCAAGUUUGGAAACGUGUtt ACACGUUUCCAAACUUGCCtt
AURKC aurora kinase C 6795 NM 003160,NM 001015878,NM 001015 111219 GCGAGAAAUUAGAUGAACAtt UGUUCAUCUAAUUUCUCGCtt
AURKC aurora kinase C 6795 NM 003160,NM 001015878,NM 001015 379 GGAAAGCCAUUUCAUUGUGtt CACAAUGAAAUGGCUUUCCtt
AURKC aurora kinase C 6795 NM 003160,NM 001015878,NM 001015 378 GGUAGAUGUGAGGUUUCCAtt UGGAAACCUCACAUCUACCtt
BIRC5 baculoviral IAP repeat-containing 5 (survivin 332 NM 001168,NM 001012270,NM 001012 121296 GGCAGUGGCCUAAAUCCUUtt AAGGAUUUAGGCCACUGCCtt
BIRC5 baculoviral IAP repeat-containing 5 (survivin 332 NM 001168,NM 001012270,NM 001012 121295 GCCAUUCUAAGUCAUUGGGtt CCCAAUGACUUAGAAUGGCtt
BIRC5 baculoviral IAP repeat-containing 5 (survivin 332 NM 001168,NM 001012270,NM 001012 121294 CCACUUCCAGGGUUUAUUCtt GAAUAAACCCUGGAAGUGGtg
BUB1 BUB1 budding uninhibited by benzimidazole 699 NM_004336, 510 GGCAAAAGCUGAAGAAAGUtt ACUUUCUUCAGCUUUUGCCtt
BUB1 BUB1 budding uninhibited by benzimidazole 699 NM_004336, 509 GGUUAUUUCAGACACGCCUtt AGGCGUGUCUGAAAUAACCtg
BUB1 BUB1 budding uninhibited by benzimidazole 699 NM_004336, 147346 CGAAGAGUGAUCACGAUUUtt AAAUCGUGAUCACUCUUCGtt
BUB1B BUB1 budding uninhibited by benzimidazole 701 NM_001211, 90 GGUGGGAAGGAGAGUAAUAtt UAUUACUCUCCUUCCCACCtt
BUB1B BUB1 budding uninhibited by benzimidazole 701 NM_001211, 89 GGCUUCAGAAAUGUAACAAtt UUGUUACAUUUCUGAAGCCtg
BUB1B BUB1 budding uninhibited by benzimidazole 701 NM_001211, 88 GGGAUUGGUGUUUCACUUGtt CAAGUGAAACACCAAUCCCtt
BUB3 BUB3 budding uninhibited by benzimidazole 9184 NM_004725,NM_001007793, 137638 GCAGGGUUAUGUAUUAAGCtt GCUUAAUACAUAACCCUGCtt
BUB3 BUB3 budding uninhibited by benzimidazole 9184 NM_004725,NM_001007793, 137637 GCCUGAAAAGGUAUAUACCtt GGUAUAUACCUUUUCAGGCtg
BUB3 BUB3 budding uninhibited by benzimidazole 9184 NM_004725,NM_001007793, 15258 GGUAUAUACCCUCUCAGUGtt CACUGAGAGGGUAUAUACCtt
CCNB1 cyclin B1 891 NM_031966, 118840 GCUGAUCCAAACCUUUGUAtt UACAAAGGUUUGGAUCAGCtc
CCNB1 cyclin B1 891 NM_031966, 118839 GCCUAUUUUGGUUGAUACUtt AGUAUCAACCAAAAUAGGCtc
CCNB1 cyclin B1 891 NM_031966, 118838 GCAAAACCUUCAGCUACUGtt CAGUAGCUGAAGGUUUUGCtt
CDC10 septin 7 989 NM_001788,NM_001011553, 10504 GGGAAGAUCUUUUAAACUCtt GAGUUUAAAAGAUCUUCCCtt
CDC10 septin 7 989 NM_001788,NM_001011553, 10417 GGUCCUUCUCAUAGAAUUAtt UAAUUCUAUGAGAAGGACCtg
CDC10 septin 7 989 NM_001788,NM_001011553, 10323 GGUUUUGAAUUCACGCUUAtt UAAGCGUGAAUUCAAAACCtc
CDC14A CDC14 cell division cycle 14 homolog A (S. 8556 NM_033312,NM_033313,NM_003672, 105908 GAAAAUAGUGCACUACACCtt GGUGUAGUGCACUAUUUUCtt
CDC14A CDC14 cell division cycle 14 homolog A (S. 8556 NM_033312,NM_033313,NM_003672, 105907 GAUUUUGGACCGCUGAACUtt AGUUCAGCGGUCCAAAAUCtg
CDC14A CDC14 cell division cycle 14 homolog A (S. 8556 NM_033312,NM_033313,NM_003672, 105906 GCACAGUAAAUACCCACUAtt UAGUGGGUAUUUACUGUGCtt
CDC14B CDC14 cell division cycle 14 homolog B (S. 8555 NM_033331,NM_033332,NM_003671, 45650 GAUUUUGGACCACUCAAUCtt GAUUGAGUGGUCCAAAAUCtg
CDC14B CDC14 cell division cycle 14 homolog B (S. 8555 NM_033331,NM_033332,NM_003671, 45559 GAACUUCUACGCAGAUUUUtt AAAAUCUGCGUAGAAGUUCtc
CDC14B CDC14 cell division cycle 14 homolog B (S. 8555 NM_033331,NM_033332,NM_003671, 35174 GGUGAUAGACUUCGGGCCUtt AGGCCCGAAGUCUAUCACCtt
CDC16 CDC16 cell division cycle 16 homolog (S. ce 8881 NM_003903, 137341 GCCUAGUGAAACGGUCAUCtt GAUGACCGUUUCACUAGGCtt
CDC16 CDC16 cell division cycle 16 homolog (S. ce 8881 NM_003903, 137340 GCGACUGGGAAAUGUCACAtt UGUGACAUUUCCCAGUCGCtg
CDC16 CDC16 cell division cycle 16 homolog (S. ce 8881 NM_003903, 137342 CCAAUAACUCAAAACUAGCtt GCUAGUUUUGAGUUAUUGGtc
CDC2 cell division cycle 2, G1 to S and G2 to M 983 NM_033379,NM_001786, 42819 GGAACUUCGUCAUCCAAAUtt AUUUGGAUGACGAAGUUCCtt
CDC2 cell division cycle 2, G1 to S and G2 to M 983 NM_033379,NM_001786, 1625 GGUUAUAUCUCAUCUUUGAtt UCAAAGAUGAGAUAUAACCtg
CDC2 cell division cycle 2, G1 to S and G2 to M 983 NM_033379,NM_001786, 1440 GGUCAAGUGGUAGCCAUGAtt UCAUGGCUACCACUUGACCtg
CDC20 CDC20 cell division cycle 20 homolog (S. ce 991 NM_001255, 215139 CCUUGUGGAUUGGAGUUCUtt AGAACUCCAAUCCACAAGGtt
CDC20 CDC20 cell division cycle 20 homolog (S. ce 991 NM_001255, 145701 CCAGCUAGUUAUUUGGAAGtt CUUCCAAAUAACUAGCUGGtt
CDC20 CDC20 cell division cycle 20 homolog (S. ce 991 NM_001255, 145700 CCUGCCGUUACAUUCCUUCtt GAAGGAAUGUAACGGCAGGtc
CDCA1 cell division cycle associated 1 83540 NM_031423,NM_145697, 131098 GGACCUUUCAGAUAAUAGGtt CCUAUUAUCUGAAAGGUCCtg
CDCA1 cell division cycle associated 1 83540 NM_031423,NM_145697, 131097 GCAUGCCGUGAAACGUAUAtt UAUACGUUUCACGGCAUGCtt
CDCA1 cell division cycle associated 1 83540 NM_031423,NM_145697, 131099 CGCACAGUAAUUGAGGAUUtt AAUCCUCAAUUACUGUGCGtt
CDCA1 kinesin heavy chain member 2 3796 NM_004520, 118425 CGUAGAAAAUCUAAUUGUGtt CACAAUUAGAUUUUCUACGtg
CDCA8 cell division cycle associated 8 55143 NM_018101, 132285 GGUCAAGCCGUGCUAACACtt GUGUUAGCACGGCUUGACCtt
CDCA8 cell division cycle associated 8 55143 NM_018101, 132284 GGUAGAUGAAAUGAUAGUGtt CACUAUCAUUUCAUCUACCtg
CDCA8 cell division cycle associated 8 55143 NM_018101, 132286 GGCUUAUUGUUUGAGUGUGtt CACACUCAAACAAUAAGCCtg
CENPE centromere protein E, 312kDa 1062 NM_001813, 121339 GCUACUAAAUCAGGAGAAUtt AUUCUCCUGAUUUAGUAGCtt
CENPE centromere protein E, 312kDa 1062 NM_001813, 121337 CCAAUCAUCGAUUCUGCCAtt UGGCAGAAUCGAUGAUUGGtg
CENPE centromere protein E, 312kDa 1062 NM_001813, 10706 GGAAUUAAAGGCUAAAAGAtt UCUUUUAGCCUUUAAUUCCtg
CENPF centromere protein F, 350/400ka (mitosin) 1063 NM_016343, 146738 GGUGACUCCAAGUCGAUCAtt UGAUCGACUUGGAGUCACCtc
CENPF centromere protein F, 350/400ka (mitosin) 1063 NM_016343, 146737 CCAAGUCAAUAUUAUAGUGtt CACUAUAAUAUUGACUUGGtg
CENPF centromere protein F, 350/400ka (mitosin) 1063 NM_016343, 146739 GGUCGAUGAAUUAACAACUtt AGUUGUUAAUUCAUCGACCtt
CEP1 centrosomal protein 1 11064 NM_007018, 136173 GCUAUAAUCUAAUAGGGAAtt UUCCCUAUUAGAUUAUAGCtg
CEP1 centrosomal protein 1 11064 NM_007018, 136172 GGAGUUAGAUAUAUUACAGtt CUGUAAUAUAUCUAACUCCtg
CEP1 centrosomal protein 1 11064 NM_007018, 136174 GCCACUAAAUUAUUAUCCAtt UGGAUAAUAAUUUAGUGGCtc
ch-TOG cytoskeleton associated protein 5 9793 NM_014756,NM_001008938, 122705 GGUGUUCAAUCAACCUAAAtt UUUAGGUUGAUUGAACACCtt
ch-TOG cytoskeleton associated protein 5 9793 NM_014756,NM_001008938, 122704 GGUGUUGUAAGUAAGGUGUtt ACACCUUACUUACAACACCtg
ch-TOG cytoskeleton associated protein 5 9793 NM_014756,NM_001008938, 122703 GCAAGGUUAAGUGGGUAUGtt CAUACCCACUUAACCUUGCtt
CHC1 chromosome condensation 1 1104 NM_001269, 145718 GGAAACGACCACUUGGUGAtt UCACCAAGUGGUCGUUUCCtg
CHC1 chromosome condensation 1 1104 NM_001269, 145717 CCGUGUGUCUAAGCAAAAGtt CUUUUGCUUAGACACACGGtg
CHC1 chromosome condensation 1 1104 NM_001269, 145719 GCAUACAGUCUUAUUAGUCtt GACUAAUAAGACUGUAUGCtg
CIT citron (rho-interacting, serine/threonine kina 11113 NM_007174, 103737 GGAUAAAUUAAGGGUCAUUtt AAUGACCCUUAAUUUAUCCtg
CIT citron (rho-interacting, serine/threonine kina 11113 NM_007174, 103729 GGGAUAUUAGAUGCCCUCUtt AGAGGGCAUCUAAUAUCCCtt
CIT citron (rho-interacting, serine/threonine kina 11113 NM_007174, 103721 GGCUGAAUCUGUUCUUCCAtt UGGAAGAACAGAUUCAGCCtg
CLASP1 cytoplasmic linker associated protein 1 23332 NM_015282, 136867 GCACAGACUUUAACACUAAtt UUAGUGUUAAAGUCUGUGCtc
CLASP1 cytoplasmic linker associated protein 1 23332 NM_015282, 136866 CCAUGUUAGAUAAACUUGUtt ACAAGUUUAUCUAACAUGGtc
CLASP1 cytoplasmic linker associated protein 1 23332 NM_015282, 136868 CGACACAUAUCAGUAUUAGtt CUAAUACUGAUAUGUGUCGtt
CSNK2B casein kinase 2, beta polypeptide 1460 NM_001320, 9896 GGAACCCUGUAUGGUUUUUtt AAAAACCAUACAGGGUUCCtg
CSNK2B casein kinase 2, beta polypeptide 1460 NM_001320, 9806 GGAGACUUUGGUUACUGUCtt GACAGUAACCAAAGUCUCCtt
CSNK2B casein kinase 2, beta polypeptide 1460 NM_001320, 9710 GGCAGCCGAGAUGCUUUAUtt AUAAAGCAUCUCGGCUGCCtg
DCTN1 dynactin 1 (p150, glued homolog, Drosophil 1639 NM_023019,NM_004082, 242562 CCACAUUAAGUUCACGCAGtt CUGCGUGAACUUAAUGUGGtc
DCTN1 dynactin 1 (p150, glued homolog, Drosophil 1639 NM_023019,NM_004082, 242561 GGAGAAAGAGUUUGAGGAGtt CUCCUCAAACUCUUUCUCCtt
DCTN1 dynactin 1 (p150, glued homolog, Drosophil 1639 NM_023019,NM_004082, 242560 GGCAGAGAGCACCAUUGAUtt AUCAAUGGUGCUCUCUGCCtg
DCTN2 dynactin 2 (p50) 10540 NM_006400, 135759 GGUGCACCAGCUAUAUGAAtt UUCAUAUAGCUGGUGCACCtt
DCTN2 dynactin 2 (p50) 10540 NM_006400, 135758 GGACAGGAUAUGAAUCUGGtt CCAGAUUCAUAUCCUGUCCtc
DCTN2 dynactin 2 (p50) 10540 NM_006400, 135757 GCGGAGUUCGAUGCGUUUGtt CAAACGCAUCGAACUCCGCtt
DLG7 discs, large homolog 7 (Drosophila) 9787 NM_014750, 138400 GCCAAAAAAGGCUAUUCCAtt UGGAAUAGCCUUUUUUGGCtc
DLG7 discs, large homolog 7 (Drosophila) 9787 NM_014750, 138399 CGAAAUAGACACUUUGGUUtt AACCAAAGUGUCUAUUUCGtt
DLG7 discs, large homolog 7 (Drosophila) 9787 NM_014750, 138401 CGAGGAAUAUUUAAAGUGGtt CCACUUUAAAUAUUCCUCGtt
DNCH1 dynein, cytoplasmic, heavy polypeptide 1 1778 NM_001376, 118311 GCCAAAAGUUACAGACUUUtt AAAGUCUGUAACUUUUGGCtt
DNCH1 dynein, cytoplasmic, heavy polypeptide 1 1778 NM_001376, 118310 GCAAAAUAUUGAAAUUCCGtt CGGAAUUUCAAUAUUUUGCtg
DNCH1 dynein, cytoplasmic, heavy polypeptide 1 1778 NM_001376, 118309 CGUACUCCCGUGAUUGAUGtt CAUCAAUCACGGGAGUACGtt
ECT2 epithelial cell transforming sequence 2 onco 1894 NM_018098, 26257 GGCCAAUAAUUUAAGUUGCtt GCAACUUAAAUUAUUGGCCtt
ECT2 epithelial cell transforming sequence 2 onco 1894 NM_018098, 26165 GGUUUGGAUUCUCCGGAAUtt AUUCCGGAGAAUCCAAACCtt
ECT2 epithelial cell transforming sequence 2 onco 1894 NM_018098, 26070 GGACAUUAAAGUGGGCUUUtt AAAGCCCACUUUAAUGUCCtt
ESPL1 extra spindle poles like 1 (S. cerevisiae) 9700 NM_012291, 121653 CCAUUAAUAAAAAGUGUCCtt GGACACUUUUUAUUAAUGGtg
ESPL1 extra spindle poles like 1 (S. cerevisiae) 9700 NM_012291, 121652 GCAGCUGACUGCUAAGCUAtt UAGCUUAGCAGUCAGCUGCtg
ESPL1 extra spindle poles like 1 (S. cerevisiae) 9700 NM_012291, 121651 GCUUGUGAUGCCAUCCUGAtt UCAGGAUGGCAUCACAAGCtt
FZR1 fizzy/cell division cycle 20 related 1 (Drosop 51343 NM_016263, 241641 UUAAAUGCCUGAUUGUGAAtt UUCACAAUCAGGCAUUUAAtg
FZR1 fizzy/cell division cycle 20 related 1 (Drosop 51343 NM_016263, 241640 GCAAAACCCGUUCGACAAAtt UUUGUCGAACGGGUUUUGCta
FZR1 fizzy/cell division cycle 20 related 1 (Drosop 51343 NM_016263, 241639 GUCAGAACCGGAAAGCCAAtt UUGGCUUUCCGGUUCUGACtg
INCENP inner centromere protein antigens 135/155k 3619 NM_020238, 28431 GGAGAAGAAGAAGCAGAUUtt AAUCUGCUUCUUCUUCUCCtc
INCENP inner centromere protein antigens 135/155k 3619 NM_020238, 145370 CGGAAGAAGAGACGGAUUUtt AAAUCCGUCUCUUCUUCCGtc
INCENP inner centromere protein antigens 135/155k 3619 NM_020238, 145369 GCGCAUGUUCACCAGAGAAtt UUCUCUGGUGAACAUGCGCtc
INCENP inner centromere protein antigens 135/155k 3619 NM_020238, 28244 GGACUUGGUGUGGCUUGAGtt CUCAAGCCACACCAAGUCCtt
KEAP1 kelch-like ECH-associated protein 1 9817 NM_012289,NM_203500, 138235 CGAGUGGCGAAUGAUCACAtt UGUGAUCAUUCGCCACUCGtt
KEAP1 kelch-like ECH-associated protein 1 9817 NM_012289,NM_203500, 138234 GGAACGAGUGGCGAAUGAUtt AUCAUUCGCCACUCGUUCCtc
KEAP1 kelch-like ECH-associated protein 1 9817 NM_012289,NM_203500, 138233 CGGGACAAACCGCCUUAAUtt AUUAAGGCGGUUUGUCCCGtc
KIF11 kinesin family member 11 3832 NM_004523, 118431 GGAGUGAUAAUUAAAGGUUtt AACCUUUAAUUAUCACUCCtc
KIF11 kinesin family member 11 3832 NM_004523, 118430 GCUCAAGGAAAACAUACACtt GUGUAUGUUUUCCUUGAGCtc
KIF11 kinesin family member 11 3832 NM_004523, 118429 CCAUUUAAUUUGGCAGAGCtt GCUCUGCCAAAUUAAAUGGtc
KIF2 kinesin heavy chain member 2 3796 NM_004520, 118424 GCCAAAGUAAACAAAAUUGtt CAAUUUUGUUUACUUUGGCtg
KIF2 kinesin heavy chain member 2 3796 NM_004520, 118423 CCUGGAGAGCAUCUUUUCAtt UGAAAAGAUGCUCUCCAGGtc
KIF20A kinesin family member 20A 10112 NM_005733, 118443 GGUUAAAGCUAAAUUACAGtt CUGUAAUUUAGCUUUAACCtc
KIF20A kinesin family member 20A 10112 NM_005733, 118442 GCAGCAGGUUCCAUCUGAGtt CUCAGAUGGAACCUGCUGCtt
KIF20A kinesin family member 20A 10112 NM_005733, 118441 CCUGCUAUCAGACUGCUCUtt AGAGCAGUCUGAUAGCAGGtt
KIF23 kinesin family member 23 9493 NM_138555,NM_004856, 118503 CCAUAACAUGUAUGUUGCAtt UGCAACAUACAUGUUAUGGtt
KIF23 kinesin family member 23 9493 NM_138555,NM_004856, 118502 GGUUGAUGCCUUAUUAGAAtt UUCUAAUAAGGCAUCAACCtc
KIF23 kinesin family member 23 9493 NM_138555,NM_004856, 118501 CCGAAAUGGAGACUAUAAGtt CUUAUAGUCUCCAUUUCGGtt
KIF2C kinesin family member 2C 11004 NM_006845, 118446 GCAACUUGUUUUGCAUAUGtt CAUAUGCAAAACAAGUUGCtt
KIF2C kinesin family member 2C 11004 NM_006845, 118445 GCUUCUUCCCUUACAUCCGtt CGGAUGUAAGGGAAGAAGCtg
KIF2C kinesin family member 2C 11004 NM_006845, 214569 GCAGGCUAGCAGACAAAUAtt UAUUUGUCUGCUAGCCUGCtc
KIF4A kinesin family member 4A 24137 NM_012310, 118455 GCGAAUGAAAAAAUGAACGtt CGUUCAUUUUUUCAUUCGCtt
KIF4A kinesin family member 4A 24137 NM_012310, 118454 GCAAGCGAAUGAAAAAAUGtt CAUUUUUUCAUUCGCUUGCtc
KIF4A kinesin family member 4A 24137 NM_012310, 118453 GGUAAUAGCCAUACUCUUAtt UAAGAGUAUGGCUAUUACCtc
KIF5B kinesin family member 5B 3799 NM_004521, 118428 GCUGAGUGGAAAACUUUAUtt AUAAAGUUUUCCACUCAGCtt
KIF5B kinesin family member 5B 3799 NM_004521, 118427 GCACAUCUCAAGAGCAAGUtt ACUUGCUCUUGAGAUGUGCtt
KIF5B kinesin family member 5B 3799 NM_004521, 118426 GCCUUAUGCAUUUGAUCGGtt CCGAUCAAAUGCAUAAGGCtt
KIFC1 kinesin family member C1 3833 NM_002263, 118527 CCUAAAUGCAGAACUAAAAtt UUUUAGUUCUGCAUUUAGGtc
KIFC1 kinesin family member C1 3833 NM_002263, 118526 GGCCAGACCACAGCUCAAAtt UUUGAGCUGUGGUCUGGCCtt
KIFC1 kinesin family member C1 3833 NM_002263, 118525 CGACCAAAAUUACCACAUCtt GAUGUGGUAAUUUUGGUCGtt
KNS2 kinesin 2 60/70kDa 3831 NM_005552,NM_182923, 118512 GCAUCUGGAGUUUAUGAAUtt AUUCAUAAACUCCAGAUGCtt
KNS2 kinesin 2 60/70kDa 3831 NM_005552,NM_182923, 118511 GCACAAUUCCAUUUUACAAtt UUGUAAAAUGGAAUUGUGCtc
KNS2 kinesin 2 60/70kDa 3831 NM_005552,NM_182923, 118510 GCUUUGAAGAAUGAGCACAtt UGUGCUCAUUCUUCAAAGCtt
LATS1 LATS, large tumor suppressor, homolog 1 (D 9113 NM_004690, 567 GGAGUGUUACUCCUCCACCtt GGUGGAGGAGUAACACUCCtt
LATS1 LATS, large tumor suppressor, homolog 1 (D 9113 NM_004690, 566 GGUUCUGAGAGUAAAAUUAtt UAAUUUUACUCUCAGAACCtc
LATS1 LATS, large tumor suppressor, homolog 1 (D 9113 NM_004690, 565 GGACAGAGAGGCAUUAGUUtt AACUAAUGCCUCUCUGUCCtt
LIMK1 LIM domain kinase 1 3984 NM_002314,NM_016735, 1413 GGACAAGAGGCUCAACUUCtt GAAGUUGAGCCUCUUGUCCtt
LIMK1 LIM domain kinase 1 3984 NM_002314,NM_016735, 1318 GGUGACACACCGUGAGACAtt UGUCUCACGGUGUGUCACCtt
LIMK1 LIM domain kinase 1 3984 NM_002314,NM_016735, 1223 GGAUCUAUGAUGGCCAGUAtt UACUGGCCAUCAUAGAUCCtc
LOC285643 LOC285643 285643 XM_209695, 118521 GCAAGUGAAUGAAAAACUGtt CAGUUUUUCAUUCACUUGCtc
LOC285643 LOC285643 285643 XM_209695, 118520 GGUAACAGCCACACUCUUAtt UAAGAGUGUGGCUGUUACCtc
LOC285643 LOC285643 285643 XM_209695, 118519 CCAACAGUUGGCAUUAUUCtt GAAUAAUGCCAACUGUUGGtt
MAD1L1 MAD1 mitotic arrest deficient-like 1 (yeast) 8379 NM 003550,NM 001013836,NM 001013 121449 CCAAAGUGCUGCACAUGAGtt CUCAUGUGCAGCACUUUGGtc
MAD1L1 MAD1 mitotic arrest deficient-like 1 (yeast) 8379 NM 003550,NM 001013836,NM 001013 121448 GCGAUUGUGAAGAACAUGAtt UCAUGUUCUUCACAAUCGCtg
MAD1L1 MAD1 mitotic arrest deficient-like 1 (yeast) 8379 NM 003550,NM 001013836,NM 001013 121447 GGAUGCAGCGAUUGUGAAGtt CUUCACAAUCGCUGCAUCCtg
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 4085 NM_002358, 143483 GCGUGGCAUAUAUCCAUCUtt AGAUGGAUAUAUGCCACGCtg
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 4085 NM_002358, 11455 GGAUGACAUGAGGAAAAUAtt UAUUUUCCUCAUGUCAUCCtc
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 4085 NM_002358, 11361 GGAUGAAAUCCGUUCAGUGtt CACUGAACGGAUUUCAUCCtg
MAP1B microtubule-associated protein 1B 4131 NM_032010,NM_005909, 144102 GCUCAAACAUCUAGACUUUtt AAAGUCUAGAUGUUUGAGCtt
MAP1B microtubule-associated protein 1B 4131 NM_032010,NM_005909, 144101 GCCAGCUUAACCCUGUUCUtt AGAACAGGGUUAAGCUGGCtt
MAP1B microtubule-associated protein 1B 4131 NM_032010,NM_005909, 144100 CCCUUCUGAUGAAGCAGUCtt GACUGCUUCAUCAGAAGGGtt
MAPRE1 microtubule-associated protein, RP/EB fami 22919 NM_012325, 136500 GCAGGUCAACGUAUUGAAAtt UUUCAAUACGUUGACCUGCtg
MAPRE1 microtubule-associated protein, RP/EB fami 22919 NM_012325, 136499 GCUAAGCUAGAACACGAGUtt ACUCGUGUUCUAGCUUAGCtt
MAPRE1 microtubule-associated protein, RP/EB fami 22919 NM_012325, 136501 GGUCAACGUAUUGAAACUUtt AAGUUUCAAUACGUUGACCtg
MOBK1B MOB1, Mps One Binder kinase activator-like 55233 NM_018221, 132366 GGCACAACAAGUAUUAUACtt GUAUAAUACUUGUUGUGCCtc
MOBK1B MOB1, Mps One Binder kinase activator-like 55233 NM_018221, 26356 GGAUCUCAUCAGUAUGAACtt GUUCAUACUGAUGAGAUCCtt
MOBK1B MOB1, Mps One Binder kinase activator-like 55233 NM_018221, 26450 GGGAGAGGAUCUCAAUGAAtt UUCAUUGAGAUCCUCUCCCtc
MOBKL1A MOB1, Mps One Binder kinase activator-like 92597 NM_173468, 148184 GGUUUUGGAGGUUAAUUUAtt UAAAUUAACCUCCAAAACCtc
MOBKL1A MOB1, Mps One Binder kinase activator-like 92597 NM_173468, 148183 CCAUAUUCUAUUGCUAGGGtt CCCUAGCAAUAGAAUAUGGtt
MOBKL1A MOB1, Mps One Binder kinase activator-like 92597 NM_173468, 148185 GGAUGGAUAAAACACUACAtt UGUAGUGUUUUAUCCAUCCtg
MPP1 membrane protein, palmitoylated 1, 55kDa 4354 NM_002436, 121379 CCGAGGACAUGUACACCAAtt UUGGUGUACAUGUCCUCGGtc
MPP1 membrane protein, palmitoylated 1, 55kDa 4354 NM_002436, 121381 GCACAGCUCGAUUUUUGAUtt AUCAAAAAUCGAGCUGUGCtt
MPP1 membrane protein, palmitoylated 1, 55kDa 4354 NM_002436, 121380 GCCGUCUUCCUGCACUACAtt UGUAGUGCAGGAAGACGGCtt
MSF septin 9 10801 NM_006640, 135963 CGCACGAUAUUGAGGAGAAtt UUCUCCUCAAUAUCGUGCGtg
MSF septin 9 10801 NM_006640, 18321 GGAGGAGGUCAACAUCAACtt GUUGAUGUUGACCUCCUCCtg
MSF septin 9 10801 NM_006640, 18228 GGGCUUCGAGUUCAACAUCtt GAUGUUGAACUCGAAGCCCtg
NEDD4 neural precursor cell expressed, developme 4734 NM_198400,NM_006154, 120779 GGGAUUCUUUGAACUAAUAtt UAUUAGUUCAAAGAAUCCCtc
NEDD4 neural precursor cell expressed, developme 4734 NM_198400,NM_006154, 120778 GGACCUAUUAUGUAAACCAtt UGGUUUACAUAAUAGGUCCtt
NEDD4 neural precursor cell expressed, developme 4734 NM_198400,NM_006154, 120777 GGAUAUCCUUGGAAGGACCtt GGUCCUUCCAAGGAUAUCCtg
NEDD5 septin 2 4735 NM 004404,NM 001008491,NM 001008 14802 GGCUGUCUCAUUUAUUUUUtt AAAAAUAAAUGAGACAGCCtg
NEDD5 septin 2 4735 NM 004404,NM 001008491,NM 001008 14709 GGCAAUACACAACAAGGUGtt CACCUUGUUGUGUAUUGCCtt
NEDD5 septin 2 4735 NM 004404,NM 001008491,NM 001008 14614 GGCGGCACAUCAUUGAUAAtt UUAUCAAUGAUGUGCCGCCtg
PLCB2 phospholipase C, beta 2 5330 NM_004573, 15072 GGUUGAAGAGAGAGAUUAAtt UUAAUCUCUCUCUUCAACCtc
PLCB2 phospholipase C, beta 2 5330 NM_004573, 14977 GGAGAUGGAGUUUCUGGAUtt AUCCAGAAACUCCAUCUCCtt
PLCB2 phospholipase C, beta 2 5330 NM_004573, 14881 GGGCUACUACUUAUACUGGtt CCAGUAUAAGUAGUAGCCCtt
PLK1 polo-like kinase 1 (Drosophila) 5347 NM_005030, 42856 GGAGGUGUUCGCGGGCAAGtt CUUGCCCGCGAACACCUCCtt
PLK1 polo-like kinase 1 (Drosophila) 5347 NM_005030, 1341 GGUUUUCGAUUGCUCCCAGtt CUGGGAGCAAUCGAAAACCtt
PLK1 polo-like kinase 1 (Drosophila) 5347 NM_005030, 103548 GGUGGAUGUGUGGUCCAUUtt AAUGGACCACACAUCCACCtc
PMF1 polyamine-modulated factor 1 11243 NM_007221, 253762 CCUCUGAGAACGGCUGAAAtt UUUCAGCCGUUCUCAGAGGta
PMF1 polyamine-modulated factor 1 11243 NM_007221, 253761 GUGAGGAGACCGCCAGCCCtt GGGCUGGCGGUCUCCUCACtc
PMF1 polyamine-modulated factor 1 11243 NM_007221, 253760 UUUCGAGGGUGAAGCUCCUtt AGGAGCUUCACCCUCGAAAtg
PNUTL1 septin 5 5413 NM_002688,NM_001009939, 12081 GGCAUUGCAUGAGAAGGUCtt GACCUUCUCAUGCAAUGCCtt
PNUTL1 septin 5 5413 NM_002688,NM_001009939, 11993 GGGAGUCAAGCUGAAGCUCtt GAGCUUCAGCUUGACUCCCtt
PNUTL1 septin 5 5413 NM_002688,NM_001009939, 11898 GGCUUUGACUUCACACUCAtt UGAGUGUGAAGUCAAAGCCtt
PNUTL2 septin 4 5414 NM 080415,NM 080416,NM 080417,NM 142770 GCUUGAUCCCUAUGAUUCCtt GGAAUCAUAGGGAUCAAGCtt
PNUTL2 septin 4 5414 NM 080415,NM 080416,NM 080417,NM 14882 GGAUUUCUCAGGAAAUGCGtt CGCAUUUCCUGAGAAAUCCtt
PNUTL2 septin 4 5414 NM 080415,NM 080416,NM 080417,NM 15073 GGAGAUGCUACACAAAAUAtt UAUUUUGUGUAGCAUCUCCtg
PRC1 protein regulator of cytokinesis 1 9055 NM_003981,NM_199413,NM_199414, 137453 GCGGUUACAAAGAACUGAGtt CUCAGUUCUUUGUAACCGCtg
PRC1 protein regulator of cytokinesis 1 9055 NM_003981,NM_199413,NM_199414, 137452 CCAGCGGUUACAAAGAACUtt AGUUCUUUGUAACCGCUGGtc
PRC1 protein regulator of cytokinesis 1 9055 NM_003981,NM_199413,NM_199414, 137454 CCAUUAUGUCUGGGUCAAAtt UUUGACCCAGACAUAAUGGtg
PTTG1 pituitary tumor-transforming 1 9232 NM_004219, 42068 GAGUUUGUGUGUAUUUGUAtt UACAAAUACACACAAACUCtg
PTTG1 pituitary tumor-transforming 1 9232 NM_004219, 41990 GUCUGUAAAGACCAAGGGAtt UCCCUUGGUCUUUACAGACtt
PTTG1 pituitary tumor-transforming 1 9232 NM_004219, 41900 GAUCUCAAGUUUCAACACCtt GGUGUUGAAACUUGAGAUCtc
RAB8A RAB8A, member RAS oncogene family 4218 NM_005370, 3022 GGAAAGCACAAAUGAAGGAtt UCCUUCAUUUGUGCUUUCCtt
RAB8A RAB8A, member RAS oncogene family 4218 NM_005370, 2930 GGGAGUCAAAAUCACACCGtt CGGUGUGAUUUUGACUCCCtg
RAB8A RAB8A, member RAS oncogene family 4218 NM_005370, 2836 GGCCAACAUCAAUGUGGAAtt UUCCACAUUGAUGUUGGCCtt
RABGAP1 RAB GTPase activating protein 1 23637 NM_012197, 147469 GGAAUUGUGAGACUCUUAGtt CUAAGAGUCUCACAAUUCCtt
RABGAP1 RAB GTPase activating protein 1 23637 NM_012197, 147468 CCCUGUGCCAUUAGUAGGGtt CCCUACUAAUGGCACAGGGtt
RABGAP1 RAB GTPase activating protein 1 23637 NM_012197, 147470 GCUGUAAGCCGGAUACUUUtt AAAGUAUCCGGCUUACAGCtt
RACGAP1 Rac GTPase activating protein 1 29127 NM_013277, 20374 GGCAACUUUUUUGCUUCUCtt GAGAAGCAAAAAAGUUGCCtt
RACGAP1 Rac GTPase activating protein 1 29127 NM_013277, 20283 GGAUUUCCGUAAAAAGUGGtt CCACUUUUUACGGAAAUCCtc
RACGAP1 Rac GTPase activating protein 1 29127 NM_013277, 20189 GGACUUUGAGGAUUUCCGUtt ACGGAAAUCCUCAAAGUCCtt
RASSF1 Ras association (RalGDS/AF-6) domain fam 11186 NM 007182,NM 170712,NM 170713,NM 137076 GGAUAUCCUUAUCAGAGCUtt AGCUCUGAUAAGGAUAUCCtg
RASSF1 Ras association (RalGDS/AF-6) domain fam 11186 NM 007182,NM 170712,NM 170713,NM 137075 CGGUUCUUACACAGGCUUCtt GAAGCCUGUGUAAGAACCGtc
RASSF1 Ras association (RalGDS/AF-6) domain fam 11186 NM 007182,NM 170712,NM 170713,NM 40417 GGUUCAGCUGAAGCUGGUGtt CACCAGCUUCAGCUGAACCtt
Rif1 RAP1 interacting factor homolog (yeast) 55183 NM_018151, 223389 CCACAUUUUUUCAGAACAGtt CUGUUCUGAAAAAAUGUGGtt
Rif1 RAP1 interacting factor homolog (yeast) 55183 NM_018151, 223388 CCUGAGUUCGAAUUUAGGUtt ACCUAAAUUCGAACUCAGGtt
Rif1 RAP1 interacting factor homolog (yeast) 55183 NM_018151, 223387 GCACUUUGGGUGAUAUCUAtt UAGAUAUCACCCAAAGUGCtc
ROCK2 Rho-associated, coiled-coil containing prote 9475 NM_004850, 596 GGAAAGAACUUUAAAACAGtt CUGUUUUAAAGUUCUUUCCtc
ROCK2 Rho-associated, coiled-coil containing prote 9475 NM_004850, 595 GGUGCUUUUGGUGAAGUGCtt GCACUUCACCAAAAGCACCtc
ROCK2 Rho-associated, coiled-coil containing prote 9475 NM_004850, 110867 GGCCACAAAGGCACGACUAtt UAGUCGUGCCUUUGUGGCCtt
RSN restin (Reed-Steinberg cell-expressed interm 6249 NM_002956,NM_198240, 241427 AUCAAUUACCAAAGGUGAUtt AUCACCUUUGGUAAUUGAUtc
RSN restin (Reed-Steinberg cell-expressed interm 6249 NM_002956,NM_198240, 241426 CCUUCAGUUCCGGGUUGAAtt UUCAACCCGGAACUGAAGGtc
RSN restin (Reed-Steinberg cell-expressed interm 6249 NM_002956,NM_198240, 142518 GGUAAAUCGGAAAUGAAGAtt UCUUCAUUUCCGAUUUACCtt
RSU1 Ras suppressor protein 1 6251 NM_152724,NM_012425, 143078 CCGAGAUAUGCUAAUUUAAtt UUAAAUUAGCAUAUCUCGGtg
RSU1 Ras suppressor protein 1 6251 NM_152724,NM_012425, 108352 GGCCGUAGCAGUUUGACGAtt UCGUCAAACUGCUACGGCCtt
RSU1 Ras suppressor protein 1 6251 NM_152724,NM_012425, 3713 GGUGCUCAACUUUUUUAAUtt AUUAAAAAAGUUGAGCACCtc
SEC5L1 SEC5-like 1 (S. cerevisiae) 55770 NM_018303, 147719 GGUGCAAGUUUUCAAGAAAtt UUUCUUGAAAACUUGCACCtc
SEC5L1 SEC5-like 1 (S. cerevisiae) 55770 NM_018303, 147718 GGACUUAGAAAUGCUAUUCtt GAAUAGCAUUUCUAAGUCCtt
SEC5L1 SEC5-like 1 (S. cerevisiae) 55770 NM_018303, 147717 GGAACAAAGGAAUUCCGCCtt GGCGGAAUUCCUUUGUUCCtg
SEC8L1 SEC8-like 1 (S. cerevisiae) 60412 NM_021807,NM_001037126, 147808 GCAUAAGCAUGUCCUGAACtt GUUCAGGACAUGCUUAUGCtc
SEC8L1 SEC8-like 1 (S. cerevisiae) 60412 NM_021807,NM_001037126, 147807 GCCUACGAGAAAUGUGACCtt GGUCACAUUUCUCGUAGGCtt
SEC8L1 SEC8-like 1 (S. cerevisiae) 60412 NM_021807,NM_001037126, 29348 GGACUCUGUCUACUAGUGAtt UCACUAGUAGACAGAGUCCtg
SMC2L1 SMC2 structural maintenance of chromosom 10592 NM_006444, 135817 GGGCCGAAUUACAAAAGUAtt UACUUUUGUAAUUCGGCCCtg
SMC2L1 SMC2 structural maintenance of chromosom 10592 NM_006444, 135816 GGUGGUUAUUGGUGGUAGAtt UCUACCACCAAUAACCACCtg
SMC2L1 SMC2 structural maintenance of chromosom 10592 NM_006444, 135818 GCUCUAUUAGCCAGAUUUCtt GAAAUCUGGCUAAUAGAGCtt
SMC4L1 SMC4 structural maintenance of chromosom 10051 NM 005496,NM 001002799,NM 001002 137983 GCAAUUAGAUGAAUGUGCUtt AGCACAUUCAUCUAAUUGCtt
SMC4L1 SMC4 structural maintenance of chromosom 10051 NM 005496,NM 001002799,NM 001002 137982 GGCCAGACUGAACACGAUGtt CAUCGUGUUCAGUCUGGCCtt
SMC4L1 SMC4 structural maintenance of chromosom 10051 NM 005496,NM 001002799,NM 001002 137981 GCUCCUCGGCUUAUGAUAAtt UUAUCAUAAGCCGAGGAGCtc
SPAG5 sperm associated antigen 5 10615 NM_006461, 135834 GGCCCGUUUAGAUACCAUGtt CAUGGUAUCUAAACGGGCCtc
SPAG5 sperm associated antigen 5 10615 NM_006461, 135833 CCAUCGUCCUUGUACCAUCtt GAUGGUACAAGGACGAUGGtt
SPAG5 sperm associated antigen 5 10615 NM_006461, 135835 GCAGUAGAAGAUGUUGGUAtt UACCAACAUCUUCUACUGCtg
STK3 serine/threonine kinase 3 (STE20 homolog, 6788 NM_006281, 792 GGAUAGUUUUUCAAAUAGGtt CCUAUUUGAAAAACUAUCCtg
STK3 serine/threonine kinase 3 (STE20 homolog, 6788 NM_006281, 791 GGACAUGCAAAAUUGGCAGtt CUGCCAAUUUUGCAUGUCCtt
STK3 serine/threonine kinase 3 (STE20 homolog, 6788 NM_006281, 793 GGGUCUUAUGGAAGUGUAUtt AUACACUUCCAUAAGACCCtt
STK38 serine/threonine kinase 38 11329 NM_007271, 865 GGAUUUUCUUCCAUAAUGCtt GCAUUAUGGAAGAAAAUCCtc
STK38 serine/threonine kinase 38 11329 NM_007271, 864 GGAGAAACGACUCCGGAGAtt UCUCCGGAGUCGUUUCUCCtc
STK38 serine/threonine kinase 38 11329 NM_007271, 863 GGCCUAAAAGAUGAGGAGAtt UCUCCUCAUCUUUUAGGCCtt
STK4 serine/threonine kinase 4 6789 NM_006282, 795 GGAACUAUGAAAAGAAGGGtt CCCUUCUUUUCAUAGUUCCtt
STK4 serine/threonine kinase 4 6789 NM_006282, 794 GGGACUUGAAUACCUUCAUtt AUGAAGGUAUUCAAGUCCCtt
STK4 serine/threonine kinase 4 6789 NM_006282, 796 GGGUCCUAUGGCAGCGUAUtt AUACGCUGCCAUAGGACCCtt
STK6 serine/threonine kinase 6 6790 NM 003600,NM 198433,NM 198434,NM 427 GGCAACCAGUGUACCUCAUtt AUGAGGUACACUGGUUGCCtg
STK6 serine/threonine kinase 6 6790 NM 003600,NM 198433,NM 198434,NM 426 GGAACUGGCAUCAAAACAGtt CUGUUUUGAUGCCAGUUCCtc
STK6 serine/threonine kinase 6 6790 NM 003600,NM 198433,NM 198434,NM 425 GGUCCAAAACGUGUUCUCGtt CGAGAACACGUUUUGGACCtc
STMN1 stathmin 1/oncoprotein 18 3925 NM_005563,NM_203399,NM_203401, 144044 GCGUGUUUCUAGAGAACAGtt CUGUUCUCUAGAAACACGCtt
STMN1 stathmin 1/oncoprotein 18 3925 NM_005563,NM_203399,NM_203401, 144043 GCUGACUAAUUUGUUCUGAtt UCAGAACAAAUUAGUCAGCtt
STMN1 stathmin 1/oncoprotein 18 3925 NM_005563,NM_203399,NM_203401, 144042 GCCCUCGGUCAAAAGAAUCtt GAUUCUUUUGACCGAGGGCtg
STMN3 stathmin-like 3 50861 NM_015894, 134696 CCUGUGUGUUUAAGACAUGtt CAUGUCUUAAACACACAGGtg
STMN3 stathmin-like 3 50861 NM_015894, 134695 GGGCUGGGAUAUUCCUCAUtt AUGAGGAAUAUCCCAGCCCtc
STMN3 stathmin-like 3 50861 NM_015894, 134694 CGUUCGGGUUUUGGUUUUGtt CAAAACCAAAACCCGAACGtg
TD-60 regulator of chromosome condensation 2 55920 NM_018715, 123152 GCUUUGCUAAACUAACCUAtt UAGGUUAGUUUAGCAAAGCtc
TD-60 regulator of chromosome condensation 2 55920 NM_018715, 123151 GGGUCAAAGUGCAAAGGGCtt GCCCUUUGCACUUUGACCCtt
TD-60 regulator of chromosome condensation 2 55920 NM_018715, 123150 GGAGCGCGUCAAACUUGAAtt UUCAAGUUUGACGCGCUCCtt
TPX2 TPX2, microtubule-associated protein homo 22974 NM_012112, 136426 GCCAAGGGUAGACAUACUGtt CAGUAUGUCUACCCUUGGCtt
TPX2 TPX2, microtubule-associated protein homo 22974 NM_012112, 136425 GGGCAAAACUCCUUUGAGAtt UCUCAAAGGAGUUUUGCCCtg
TPX2 TPX2, microtubule-associated protein homo 22974 NM_012112, 136427 CCUUGCCCUACUAAGAUUUtt AAAUCUUAGUAGGGCAAGGtc
TUBG1 tubulin, gamma 1 7283 NM_001070, 120784 GAACCUGUCGCCAGUAUGAtt UCAUACUGGCGACAGGUUCtc
TUBG1 tubulin, gamma 1 7283 NM_001070, 120193 CCUGUCGCCAGUAUGACAAtt UUGUCAUACUGGCGACAGGtt
TUBG1 tubulin, gamma 1 7283 NM_001070, 9227 GGGAGAAAAGAUCCAUGAGtt CUCAUGGAUCUUUUCUCCCtg
TUBG2 tubulin, gamma 2 27175 NM_016437, 120877 GCAGAUGGAAGUGACAGUUtt AACUGUCACUUCCAUCUGCtt
TUBG2 tubulin, gamma 2 27175 NM_016437, 120570 GCUUCACCUCAUGGACAACtt GUUGUCCAUGAGGUGAAGCtg
TUBG2 tubulin, gamma 2 27175 NM_016437, 120876 CCGAGAAGCAGAUGGAAGUtt ACUUCCAUCUGCUUCUCGGtc
ZW10 ZW10 homolog, centromere/kinetochore pro 9183 NM_004724, 137635 GCAGUUGGAAAGAGACUCAtt UGAGUCUCUUUCCAACUGCtg
ZW10 ZW10 homolog, centromere/kinetochore pro 9183 NM_004724, 137634 GGUGUGCAAUAUGAUUAGCtt GCUAAUCAUAUUGCACACCtc
ZW10 ZW10 homolog, centromere/kinetochore pro 9183 NM_004724, 137636 GCAAAUCGGAGAUAUUUUAtt UAAAAUAUCUCCGAUUUGCtc
ZYX zyxin 7791 NM_003461,NM_001010972, 115435 CCUCCCAGCUUCACCUAUGtt CAUAGGUGAAGCUGGGAGGtt
ZYX zyxin 7791 NM_003461,NM_001010972, 115434 GCAGUAUUGAUUUGGAGAUtt AUCUCCAAAUCAAUACUGCtc
ZYX zyxin 7791 NM_003461,NM_001010972, 139068 CCCAACAUGGUCUAGGGAUtt AUCCCUAGACCAUGUUGGGtc
 Supplementary Table 3  
 Inter Pro Meta Ana 
Precision (positive predictive value) 97.9% 95.3% 98.7% 98.4% 
Sensitivity (recall) 97.9% 96.5% 97.4% 98.4% 
 
Performance of support vector machine prediction on four classes, similar to an 
analysis by Wang M., et al., Context-based mixture model for cell phase identification 
in automated fluorescence microscopy, BMC Bioinformatics (2007). Manually 
annotated objects for interphase, prophase, metaphase, and anaphase class of the same 
data shown in Fig. 1d were used for training. Precision and sensitivity of class 
predictions were calculated for each class individually, considering the respective 
class as positive, and the respective other classes as negative. The calculations were 
based on the amount of true-positive (tp), true-negative (tn), false-positive (fp), and 
false-negative (fn) predictions. Precision is defined as tp / (tp + fp), which sometimes 
is also referred to as positive predictive value. Sensitivity is defined as tp / (tp + fn), 




Supplementary Table 4 
 Inter Pro Prometa Meta Early ana Late ana Telo 
Precision (w/o HMM) 99.8% 80.2% 84.6% 99.8% 62.7% 94.2% 82.9% 
Precision (HMM) 100.0% 100.0% 98.0% 99.8% 93.1% 100.0% 96.4% 
Sensitivity (w/o HMM) 95.5% 99.5% 97.0% 86.0% 75.0% 96.1% 97.5% 
Sensitivity (HMM) 100.0% 100.0% 100.0% 95.7% 96.4% 99.3% 100.0% 
 
Per class prediction performance compared with manual annotation of data without 
error correction (Fig. 2a) and with HMM error correction (Fig. 2f). 
 
 Supplementary Movie legends 
 
Movie 1. Time-lapse imaging of HeLa cells stably expressing the fluorescent chromatin marker H2B-
mCherry (imaged with widefield epifluorescence 20x dry objective). The movie shows a region of 
interest of 512*512*30 (x*y*t; overall movie dimensions: 1392*1040*206  (x*y*t); time-lapse: 4.6 
min. 
 
Movie 2. Object detection and supervised classification of morphologies. The contours were derived 
by the automated segmentation, and the color code for different morphology classes is as indicated in 
legend of Fig. 1B. Original data is shown in Suppl. Movie 1. 
 
Movie 3. Automated extraction of mitotic events. The movie displays 100 randomly selected examples 
for cells progressing through mitosis (same as in Fig. 2A). The cells were in silico synchronized to the 
prophase - prometaphase transition and sorted based on total prometaphase and metaphase duration. 
The morphology classes annotated as in Fig. 2A are indicated by color-coding as in the legend of Fig. 
1B. 
 
Movie 4. Classification error correction based on free hidden Markov model. The same cells as shown 
in Fig. 2A and Suppl. Movie 3 were classified based on morphological features as well as the temporal 
context. 
 
Movie 5. Time-lapse imaging of HeLa cells stably expressing the fluorescent chromatin marker H2B-
mCherry (red) and mEGFP-α-tubulin (green) with widefield epifluorescence 20x dry objective. The 
movie shows a region of interest of 512*512*30 (x*y*t). The overall movie dimensions were 
1392*1040*206 (x*y*t); time-lapse: 4.6 min. 
 
Movie 6. Annotation of spindle dynamics in movies of cells expressing H2B-mCherry and mEGFP-α-
tubulin. The movie displays 100 randomly selected examples for automatically annotated cells 
progressing through mitosis (same as in Fig. 3D). The cells were in silico synchronized to the prophase 
- prometaphase transition in the H2B-mCherry channel and sorted by total prometaphase and 
metaphase duration. The morphology classes are indicated by color-coding as indicated in the legend 
of Fig. 3A. 
 
Movie 7. Time-lapse imaging of HeLa cells stably expressing the fluorescent chromatin marker H2B-
mCherry (red) and GalT-EGFP (green) with widefield epifluorescence 10x dry objective. The movie 
shows a region of interest of 512*512*30 (x*y*t). The overall movie dimensions were 1392*1040*482 
(x*y*t); time-lapse: 2.8 min. 
 
Movie 8. Annotation of Golgi dynamics in movies of cells expressing H2B-mCherry and GalT-EGFP. 
The movie displays 100 randomly selected examples for automatically annotated cells progressing 
through mitosis (same as in Fig. 3E). The cells were in silico synchronized to the prophase - 
prometaphase transition in the H2B-mCherry channel and sorted by total prometaphase and metaphase 
duration. The morphology classes are indicated by color-coding as indicated in the legend of Fig. 3B. 
 
Movie 9. Time-lapse imaging of HeLa cells stably expressing the fluorescent chromatin marker H2B-
mCherry (red) and DNA replication factory marker EGFP-PCNA (green) with widefield 
epifluorescence 10x dry objective. The movie shows a region of interest of 350*350*54 (x*y*t; every 
2nd time point shown). The overall movie dimensions were 1392*1040*482 (x*y*t); time-lapse: 5.9 
min. 
 
 Movie 10. Annotation of S-phase progression in movies of cells expressing H2B-mCherry and EGFP-
PCNA. The movie displays 100 randomly selected examples for automatically annotated cells 
progressing through the cell cycle (same as in Fig. 3F). The cells were in silico synchronized to the G1 
– early S transition in the EGFP-PCNA channel and sorted by total S-phase duration. Every 2nd time 
point of original data is shown. The morphology classes are indicated by color-coding as indicated in 
the legend of Fig. 3C. 
 
Movie 11. Time-lapse imaging of untreated control HeLa cells stably expressing H2B-mCherry and 
Securin-mEGFP with widefield epifluorescence 20x dry objective. The movie shows a region of 
interest of 400*400*100 (x*y*t). The overall movie dimensions were 1392*1040*500 (x*y*t); time-
lapse: 2.7 min. 
 
Movie 12. Time-lapse imaging of Mad2 siRNA transfected HeLa cells stably expressing H2B-
mCherry and Securin-mEGFP with widefield epifluorescence 20x dry objective. The movie shows a 
region of interest of 400*400*100 (x*y*t). The overall movie dimensions were 1392*1040*500 
(x*y*t; time-lapse: 2.7 min). 
 
Movie 13. Time-lapse imaging of HeLa cells stably expressing H2B-mCherry and Securin-mEGFP 
with widefield epifluorescence 20x dry objective, treated with 50 ng/ml Nocodazol immediately before 
starting the imaging. The movie shows a region of interest of 400*400*100 (x*y*t). The overall movie 
dimensions were 1392*1040*500 (x*y*t); time-lapse: 2.7 min. 
 
Movie 14. Time-lapse imaging of control HeLa cells stably expressing H2B-mCherry and IBB-EGFP 
transfected with non-silencing siRNA, using widefield epifluorescence 10x dry objective. The movie 
shows 80 time frames of the entire imaging field downsampled in x/y by a factor of 2 for display. 
Original movie dimensions: 1392*1040*744 (x*y*t); time-lapse: 3.7 min. 108 movies of different 
RNAi conditions were captured simultaneously in this experiment by multi-location time-lapse 
imaging. 
 
Movie 15. Time-lapse confocal imaging of HeLa cells stably expressing H2B-mCherry and mEGFP-α-
tubulin (63x oil immersion objective). Cells were transfected with non-silencing siRNA. Movie 
dimensions are 512*512*132 (x*y*t); time-lapse: 7.1 min. 
 
Movie 16. Time-lapse confocal imaging of HeLa cells stably expressing H2B-mCherry and mEGFP-α-
tubulin (63x oil immersion objective). Cells were transfected with siRNA targeting Cdc20. Movie 
dimensions are 512*512*132 (x*y*t); time-lapse: 7.1 min. 
 
 
